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#1 Anne-Marie Carola Andersson 
 
Study of the immunogenicity and protection of a universal influenza A vaccine 
 
A. Andersson*, J.Pravsgaard Christensen, A. Randrup Thomsen 
Institute of International Health, Immunology and Microbiology, Denmark; annema@sund.ku.dk 
 
 
There is a constant threat of a potential outbreak of a severe influenza pandemic and therefore also a 
great need for a universal influenza vaccine. In addition, the available vaccines against seasonal 
epidemics are sub-optimal with their major antigen being hemagglutinin (HA). The ectodomain of 
the matrix protein 2 (M2e) is highly conserved amongst human influenza A viruses and M2e 
specific antibodies have been shown to decrease morbidity in animals infected with influenza. 
Therefore, M2e is considered to have great potential as a vaccine target. The M2e-NSP4 protein 
consists of four M2e peptides based on the H1N1 consensus sequence fused to the NSP498-135 
fragment of rotavirus. M2e-NSP4 formulated with CAF-01 proved to be highly immunogenic and 
induced M2 peptide, M2e-NSP4, and presumably native M2e IgG antibody responses quantitatively 
greater than those induced by M2 peptide immunization with CAF-01. The induced isotypes were 
primarily IgG1 and IgG2a. In addition, the sera from M2e-NSP4 immunized mice showed to be 
cross reactive with M2 peptides derived from avian, equine, and swine influenza A strains. The 
immunogenicity of the M2e-NSP4 construct was dependent on the linkage between four M2e 
peptides to the NSP4 fragment. Finally, two immunizations with 10 µg M2e-NSP4 protected 
against lethal infection with PR8. Further experiments will include studies of the M2e-NSP4 
construct with M2e based on a H5N1 sequence and the immunogenicity and protection in ferrets. 
#2 Åsa Andersson 
 
Studies of genes controlling development of disease in an experimental model for 
multiple sclerosis 
 
Kirsten Vikkelsø-Madsen1, Hera Bragadóttir1, Jeppe Mouritsen2, Freja Jacobsen1, Aase Frandsen1, 
Åsa Andersson1 
1Dept. of Pharmacology and Pharmacotherapy, Faculty of Pharmaceutical Sciences, Copenhagen 
University; 2Institute of Molecular Systems Biology, ETH Zürich, Switzerland 
 
 
AIM: To identify disease factors for Multiple Sclerosis (MS) by defining genes important for 
development of Experimental Autoimmune Encephalomyelitis (EAE), an animal model for 
Multiple Sclerosis.  
 
BACKGROUND: Development of autoimmune diseases is dependent on both hereditary and 
environmental factors. We have defined genetic regions in the mouse linked to development of 
EAE. EAE develops in susceptible mice after immunization with myelin proteins or peptides and 
leads to a T cell dependent attack on the myelin in the CNS. To further dissect the identified 
quantitative trait loci (QTL) linked to disease, and to define candidate genes within the regions, we 
have produced mice congenic for the respective genetic regions. Disease-controlling genetic regions 
from the resistant mouse strain RIIIS/J (H-2r) have been bred on to the MHC congenic susceptible 
B10.RIII strain (H-2r).  
 
RESULTS: In studies of EAE development in the congenic and littermate control mice, we have 
confirmed that the novel Eae loci Eae27 and Eae42 on mouse chromosome 1 contain genes 
controlling susceptibility to EAE. By bioinformatics, DNA sequencing, and gene expression studies 
(with real-time PCR) we have identified specific candidate genes primarily involved in T cell 
activation. The candidate genes are further studied by in vitro functional assays and flow cytometry. 
Preliminary results show that polymorphisms in genes for proteins involved in T cell signalling and 
extra-cellular glycosylation patterns located in Eae27 and Eae42, respectively, might change the T 
cell activation pattern in resistant (congenic) compared to susceptible (control) mice. 
 
CONCLUSION: Two genetic loci on mouse chromosome 1 have been identified to harbour genes 
controlling EAE. Polymorphic genes within the respective loci controlling T cell activity could be 
important for disease development. 
 
 
 
 
 
 
 
 
 
 
#3 Sara Marie Atkinson 
 
Establishment and histopathological and immunological characterization of a 
sustained delayed type hypersensitivity model with characteristics of arthritis in 
mice 
 
Sara Marie Atkinson 
Faculty of Health Sciences, University of Copenhagen; Department of Experimental Immunology, 
Novo Nordisk A/S 
 
 
The use of animal models designed to mimic important aspects of human diseases is crucial to the 
understanding of pathogenesis and provide valuable insight into how the immune system works in a 
disease setting. Moreover, animal models of disease provide an opportunity to perform pre-clinical 
screening and selection of new drug candidates. 
 
Rheumatoid arthritis (RA) is a progressive, destructive systemic autoimmune human disease, 
characterized by chronic synovial joint inflammation, including infiltration of inflammatory cells, 
fibrin deposition and cytokine-mediated enzymatic erosion of cartilage and bone. Synovial 
hyperplasia results [1]. Signs of systemic inflammation are also present, including upregulation of 
acute-phase proteins [1]. Autoantibodies against type II collagen (CII) can be detected in some RA 
patients, but it is not well understood how antibodies against type II collagen are involved in the 
progression of RA [2].  
 
 Animal models of arthritis can be induced by immunizing mice with CII antigen in Freund’s 
complete adjuvant (CFA), this model is known as collagen induced arthritis (CIA). The 
inflammatory arthritis induced following immunization develops primarily in the paws and is 
dependent on both T and B cells but also involves other inflammatory cells such as neutrophils and 
macrophages [2]. Another, mouse model of arthritis is the anti-type II collagen antibody–induced 
arthritis model (CAIA), which is induced by an injection of mixtures of anti-CII monoclonal 
antibodies followed by a subsequent injection of LPS [3]. The arthritis that develops in the CAIA 
model is highly neutrophil driven. However, T-cells are also involved [3].  
 
The immune reaction thought to underlay many autoimmune disorders is delayed-type 
hypersensitivity (DTH), a reaction that is T-cell dependent and induced by antigen [4]. The 
organism response in DTH is essentially the same as in the response to an exogenous pathogen or 
antigen. DTH elicited in murine footpads peaks 24-48 hrs after the antigen challenge, and does not 
persist for long enough for any significant bone destruction or synovial hyperplasia to occur [5].   
In the present project we would like to investigate whether injection of a mixture of anti-CII 
antibodies during the sensitization phase can induce a more sustained DTH reaction with 
characteristics of arthritis, since CII antibodies appear crucial for the development of a chronic 
inflammation in joint tissue [2]. Moreover, we would like to characterize the underlying 
histopathology and immune mechanisms. The model has been described by Tanaka et al. in Balb/c 
mice [5], However we would as a first choice aim at establishing the model in C57Bl/6 mice, since 
we already have a DTH model established in this strain. Also establishing the model in C57Bl/6 
mice is practical, as many knockout mice are only available in this strain, and for control and 
comparison purposes it is desirable to use only one mouse strain. 
 DTH is a T-cell dependent immune mediated response, which develops in two phases. In the 
sensitization phase, T cells are sensitized and antigen-specific effector T cells are formed. Next, in 
the elicitation phase, recall T-cell responses are induced upon secondary challenge with antigen. 
These effector T cells release cytokines and chemokines, which lead to activation of endothelium 
and recruitment of inflammatory cells such as neutrophils and macrophages at the site of the DTH 
reaction. In mice, the DTH reaction is typically elicited in the footpad, and result in a transient acute 
footpad swelling that peaks at 24 hrs. This transient DTH model has several advantages. It is a short 
(7 days + 2-3 days) and highly reproducible animal model. Moreover, a DTH reaction is only seen 
in the antigen-challenged footpad and draining lymph node (LN), thus the contralateral PBS 
challenged footpad (and draining LN) serves as in intra-animal control. This very site-directed and 
local reaction makes the model ideally suited for mode of action studies (MoA) and efficacy studies 
of drugs that interfere with or block T-cell priming, cell-migration or inflammatory cytokines. 
However, due to the transient nature of the DTH response the model is best suited for preventive 
treatment studies, i.e. treatment prior to elicitation. The establishment of a more sustained and 
chronic DTH model would allow therapeutic intervention and MoA studies drugs which would be 
of great value in the pre-clinical screening and selection of new drug candidates for the treatment of 
autoimmune diseases and if the model shows characteristics of arthritis it would add to its value.  
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#4 Maria Rosaria Bassi 
 
Yellow fever: a proof of concept for vaccine design 
 
Maria Rosaria Bassi, Allan R. Thomsen, Jan P. Christensen  
Department of International Heath, Immunology and Microbiology, University of Copenhagen 
 
 
Yellow fever (YF) is a severe hemorrhagic disease caused by a virus belonging to the family of 
Flaviviridae that can cause up to 50% fatality among the infected individuals. 
 
The disease is underreported and WHO estimates that YF infects as many as 200.000 people 
causing 20-30.000 deaths in Africa and Latin America. 
 
There is no cure for YF; a very safe and effective vaccine, based on a live attenuated version of the 
virus (YF-17D), is available since 1930, and over 540 million doses of it have been administered 
worldwide. 
 
Despite its success, still very little is known about how the vaccine induces protection in humans: 
limitations in understanding the vaccine-induced immunity are also due to the lack of a well-
established small animal model. 
 
This is why we aim to establish a mouse model for YF infection in our lab using the vaccine strain 
YF-17D. 
 
This model will enable us to fully characterize the composition of the innate immune response to 
the virus and to identify the lymphocytes subsets involved in the virus clearance.  
 
Once the mouse model for YF infection is established, we will adapt it to   HLA-A2.1-/HLA-DR1-
transgenic H-2 class I-/class II-knockout mice: these mice represent a unique in vivo experimental 
model for human immune function studies without any interference with mouse MHC response. We 
will use this model to validate the importance of viral epitopes targeted by human CD8+T cells, as 
identified by a collaborator, from the blood of human volunteers vaccinated with the YF17D-204. 
 
 
 
 
  
 
 
 
 
 
#5 Simon Bendsen 
 
β2 microglobulin and desLys58 β2 microglobulin and their roles in immune 
system 
 
Simon Bendsen*, Carsten Faber*, Jan Ulrik Prause#, Mogens Holst Nissen* 
*Institute of International Health, Immunology and Microbiology, University of Copenhagen; 
# Eye Pathology Section, Department of Neuroscience and Pharmacology, University of 
Copenhagen; Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital 
 
 
β2 microglobulin (β2m) is a part of the major histocompatibility complex class I, which presents 
peptides to CD8+ cells. The role the protein plays in the formation of this complex represents the so 
far only known and described function of β2m. 
  
In serum of patients undergoing chronic haemodialysis, a modified form of β2m, desLy58 β2m, is 
present. DesLys58 is formed by proteolytic cleavage by C1 complement and subsequent removal of 
Lys58  by carboxypeptidase B-like activity.  This modification of β2m can also be done in vitro. The 
modified version of the protein has, in several studies, been shown to have an apoptopic effect on 
different kinds of cells derived from the immune system.  We have shown that β2m KO develop an 
increased severity of experimental autoimmune induced uveitis (EAU) induced by the autoantigen 
interphotoreceptor retinol binding protein (IRBP) compared to wt mice. Since IRBP induced EAU 
is considered as CD4+ T-cell mediated disease it might indicate a role of β2m in regulation of the 
immune response as a negative regulator.  
 
Most cells express MHC-1 and are therefore able to bind β2m. However, the cell line K562 has no 
MHC-1 expression, but FACS-data show that desLys58 β2m and β2m are bound to the cell surface 
as detected by antibodies recognizing b2m and desLys58b2m. In addition, binding of desLys58b2m 
cannot be displaced by excessive amounts of b2m. This indicates the presence of an unknown 
receptor for β2m and/or desLys58 β2m on the surface of these cells. In our future efforts we will 
focus on identifying the presence of a possible new receptor for desLys58 β2m and elaborate on 
whether this protein interaction is of importance for the increased severity of EAU observed in β2m 
KO mice. 
 
 
#6 Lasse Boding  
 
Polymorphisms of the T cell receptor CD3delta and CD3epsilon chains affect 
anti-CD3 antibody binding and T cell activation 
 
Lasse Boding, Martin Weiss Nielsen, Charlotte Menné Bonefeld, Bodil L. Nielsen, Jens Peter H. 
Lauritsen, Marina Rode von Essen, Ann Kathrine Hansen, Morten Milek Nielsen, Martin Kongsbak, 
Maria Rubin, Marie T. Vennegaard, Niels Ødum, Carsten Geisler 
Department of International Health, Immunology and Microbiology, Faculty of Health Sciences, 
University of Copenhagen, DK-2200 Copenhagen, Denmark 
 
 
T cell receptor (TCR) structure and function have been thoroughly studied for decades. Production 
and analyses of knock-out and knock-in mice with mutations in the CD3 chains have contributed 
significantly to these studies. The generation of such gene-modified mice relies on the availability 
of suitable embryonic stem (ES) cell lines. Traditionally, ES cell lines from the 129 mouse strains 
have been used followed by backcrossing to the C57BL/6 strain. In the present study, we 
demonstrate the existence of polymorphisms in the CD3 genes from mice of the 129 and C57BL/6 
strains. These polymorphisms result in amino acid substitutions in the ectodomains of both the 
CD3delta and CD3epsilon chains in 129 mice compared to C57BL/6 mice. The amino acid 
substitutions do not change the stoichiometry or surface expression level of the TCR complex in 
129 T cells but cause reduced anti-CD3 antibody binding to 129 T cells. Further, when stimulated 
with mitogenic anti-CD3 antibodies, T cells from the 129 strains show reduced expression of the 
activation marker CD69, Ca2+ flux, IL-2 production and proliferative responses compared to 
C57BL/6 T cells. These findings demonstrate that polymorphisms of the CD3delta and epsilon 
ectodomains exist in mice, and that some of these polymorphisms lead to amino acid substitutions 
which cause structural changes and affect anti-CD3 antibody binding. Thus, functional T cell 
studies should be interpreted with caution when anti-CD3 antibodies are used for stimulation of T 
cells derived from gene-modified mice originating from 129 ES cell lines. 
#7 Christina Pries Bramsnæs 
 
Analysis of antiviral T cell responses primed through adenoviral vaccines 
encoding multiple viral antigens 
 
Christina Pries Bramsnæs, Michael Kofoed-Nielsen, Peter Holst, Allan Randrup Thomsen, Jan 
Pravsgaard Christensen, Christina Bartholdy 
Institute of International Health, Immunology and Microbiology, University of Copenhagen 
 
 
The aim of this newly started project is to analyze the T cell response raised by adenoviral vaccines  
encoding multiple viral proteins under the same promoter.  
 
T cells constitute an important part of the defense against viruses, intracellular bacteria and tumors. 
For that reason, vaccines that induce strong T cell responses, are in focus for treatment of several 
malignant diseases, as well as for infections like HIV, Hepatitis C virus and Tuberculosis, for which 
normal antibody-based vaccines have proven inefficient. Replication deficient adenoviral vectors 
encoding microbial or tumor antigens are promising vaccine candidates, as they can induce strong 
antigen-specific T cell responses upon vaccination. Using such vectors, it is also possible to 
construct multivalent vaccines that encode more than one antigen.  However,  T cell responses tend 
to be focused towards a small number of epitopes as a consequence of immunodominance occurring 
at the antigen and/or T cell level; a feature that not only increases the risk of selecting viral or tumor 
escape variants, but also challenges the concept of vaccinating against multiple antigens in the same 
vector. We want to study this phenomenon further and have for this purpose constructed adenoviral 
vectors encoding two or three antigens under the same promoter. Preliminary results with constructs 
encoding the glycoprotein (GP) from lymphocytic choriomeningitis virus (LCMV) followed by the 
second matrix protein (M2) from murine gammaherpes virus 68 (MHV68) have shown that the 
strengths and the breath of the T cell response to especially the M2 gene is compromised upon 
vaccination, when compared to constructs encoding the M2 gene alone. We will extrapolate on the 
findings using other combinations of viral genes and change the order, of which they appear in the 
construct. Moreover, we will analyze the functional relevance of the compromised T cell response 
by measuring the protection level towards subsequent viral challenge with LCMV or MHV68 in 
mice. Finally, we will look into various factors of importance for T cell competition, including 
affinity to the MHC:ag complex, T cell precursor frequencies and competition at the APC level. 
This information is of significance relevance for design of T cell-based vaccines with broad 
specificities.  
 
#8 Peter Brændstrup 
 
Novel T-cell epitopes in the immunodominant proteins IE-1 and IE-2 in human 
cytomegalovirus (CMV) 
 
Peter Brændstrup1, Lars Vindeløv2, Søren Buus1, Anette Stryhn1 
1Laboratory of Experimental Immunology, Faculty of Health Sciences, University of Copenhagen, 
Denmark; 2The Allogeneic Hematopoietic Cell Transplantation Laboratory, Department of 
Hematology, Rigshospitalet, Copenhagen University Hospital, Denmark 
 
 
Background: Latent CMV infection in recipients of hematopoietic cell transplants and solid organ 
transplants is associated with increased morbidity and mortality compared to non-infected recipients 
despite the advent of antivirals and preemptive therapy. T-cells are of crucial importance in virus 
control. IE-1 and IE-2 are among the most frequently recognized CMV proteins. 
 
Methods: In this project we used a rational approach for complete identification of  CD8 and CD4 
T-cell epitopes in IE-1 and IE-2. Matrices of IE-1 and IE-2 (pooled 15-mer peptides) were used to 
stimulate PBMC’s from 16 healthy seropositive  donors. T-cells were analysed after either a 6 hour 
stimulation period or a 24 hour stimulation period followed by 8 days of expansion. After 
stimulation CMV specific T-cells were detected by cytokine flow cytometry. The 15-mer peptides 
found to elicit T-cell responses along with the HLA-profile of the donor were then subjected to a 
prediction programme capable of suggesting possible restriction and the exact length of the peptide.  
 
Results: We have so far found four new HLA class I epitopes in IE-1 and IE-2 as well as several 
HLA class II epitopes. Current work focuses on determining the HLA restriction of the novel 
epitopes and determining the binding affinity between the predicted peptide and HLA-molecule. 
 
Conclusion: We report four novel IE-1 and IE-2 HLA class I epitopes and more importantly 
several new IE-1 and IE-2 HLA class II epitopes. The latter may be of importance in the 
development vaccine and immune therapies against CMV as little is known about CD4 T cell 
responses. We are currently working on validating these results. 
#9 Thomas H.R. Carlsen 
 
Development of novel JFH1-based Core-NS2 cell culture recombinants for HCV 
genotypes 1a, 1b and 3a using previously identified adaptive mutations 
 
Thomas H.R. Carlsen*†, Troels K.H. Scheel*†, Nina Weis*, Judith M. Gottwein*†, Jens Bukh*† 
*Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases and Clinical 
Research Centre, Copenhagen University Hospital, Hvidovre; †Department of International Health, 
Immunology, and Microbiology, Faculty of Health Sciences, University of Copenhagen, Denmark 
 
 
Hepatitis C virus (HCV) chronically infects 180 million worldwide and leads to increased risk of 
end-stage liver diseases. No vaccine exists and current treatment cures only 40-80% of patients 
depending on HCV genotype. Furthermore development of specific antivirals and a vaccine has 
been hampered by the lack of laboratory based cell culture systems. However the recent 
development of complete viral life-cycle in vitro systems, depending on the genotype 2a isolate 
JFH1, has improved the research prospects for HCV. 
 
We previously developed HCV cell culture systems for all seven genotypes and relevant subtypes 
by replacing the structural genes (Core, E1 and E2), p7 and NS2 from JFH1 by corresponding 
sequences of HCV prototype isolates. For most recombinants, efficient production of infectious 
viral particles in Huh7.5 hepatoma cells depended on adaptive mutations. These recombinants can 
be used for genotype-specific functional analysis of Core-NS2 and studies of susceptibility to 
neutralizing antibodies and antiviral drugs. However, for identification of HCV genotype-, subtype-
, or isolate-specific differences, a panel of Core-NS2 recombinants for each genotype is required.  
In this study, we developed a panel of efficient genotype 1a, 1b, and 3a Core-NS2 recombinants 
using previously identified adaptive mutations. Following transfection of mutants, one novel 
genotype 1a and 1b recombinant exhibited immediate viral spread in culture. For other 1a, 1b and 
3a isolates, introduction of mutations accelerated growth kinetics, although additional changes were 
required for efficient virus production. Furthermore, in two cases, for a 1a and a 1b recombinant, 
culture adaptation occurred only after introduction of previously identified mutations. 
In conclusion, through introduction of previously identified adaptive mutations we developed 
additional novel JFH1-based cell culture Core-NS2 recombinants for worldwide important 
genotypes. The novel recombinants will be important tools for future HCV research. 
 
#10 Katja Denninger 
The collagen induced arthritis (CIA) model: A purely rheumatoid model? 
 
Katja Denninger1, Tord Labuda2, Lars Svensson2, John Zibert2, Kristian Möller2, Marianne L. 
Bengtson2, Åsa Andersson1 
1Copenhagen University, Faculty of Pharmaceutical Science; 2LEO Pharma A/S, Ballerup, 
Denmark 
 
 
Objective: To study the angiogenesis and bone remodelling of the CIA model.  
 
Introduction: The CIA model is used as a widely accepted model of rheumatoid arthritis (RA). It is also 
used as a model for other arthritides like psoriatic arthritis (PsA), mostly due to lack of better disease models. 
However, PsA and RA are two different inflammatory arthritidies differing in particular in angiogenesis and 
bone remodelling: While RA is a purely erosive disease, bone formation and bone erosion co-exist in PsA 
and new blood vessels have a different clinical appearance in PsA than RA (1). However, bone formation 
may not be coupled to inflammation, as treatment of patients suffering from AS with TNFa blockers do not 
stop ankylosing disease progression (1). Likewise, in Spondylosing ankylosis bone erosion and bone 
formation was seen in anatomically different positions and at different time points as judged by ultrasound 
scanning of enthesitis (2). On the other hand, in some studies a partly relationship between inflammation and 
pathologic bone formation was suggested (3; 4). The angiogenesis and bone remodelling in the CIA model 
has received less attention than other aspects of the disease in this model, however, bone formation can be 
seen with histology and mRNA of bone morphogenetic protein-1 (BMP-1) is up regulated in early disease 
(5). 
 
Results: (Experiments conducted): 
- Kinetic studies of H-E stained tarsal joints  
- Gene expression (microarray) studies on tarsal joints with severe inflammation. 
The experiments are performed, but awaiting data analysis 
 
Future experiments: Kinetic studies of immunohistochemical staining for relevant antibodies. This will be 
coupled with serum analysis for biomarkers of erosive disease and in vivo imaging.  
 
Perspectives: The final aim of the studies is to compare the CIA model to two new models of PsA under 
way in order to characterise, evaluate and compare the models for their usefulness as disease models of PsA.  
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#11 Sanne Diemer 
Stability and purity of capsaicin 
 
Sanne Diemer, Mogens H. Claesson, Nanna Ny Kristensen 
Department of International Health, Immunology and Microbiology, The Faculty of Health 
Sciences, Copenhagen, Denmark 
 
Capsaicin, the hot ingredient of chilli peppers, has pain and inflammation relieving 
potential by desensitizing or killing pain transmitting afferent neurons.  Recently, we 
showed that prophylactic capsaicin treatment could prevent development of 
inflammation in the T cell transfer model of chronic colitis.  
Problems with solubility of capsaicin led us to suspect the stability of capsaicin 
dissolved in standard PBS/ethanol/tween80 containing vehicle.  
The stability of capsaicin was studied at different temperatures (20°C, 37°C, and 
74°C) and at varying time intervals (15 min – 6 days).  Capsaicin samples were 
subsequently analyzed by high-performance liquid chromatography (HPLC) and mass 
spectrometry (MS). 
Batches of capsaicin from two suppliers were analyzed. A batch of capsaicin (purity of 
98%, Calbiochem, Canada) was used in stability testing and shown to be stable in all 
the experimental settings mentioned above. However, by analyzing the purity of this 
batch by HPLC at 281 nm a significant diversity of the indicated 98% purity was 
observed, since only 61% purity was recorded. The Calbiochem batch of capsaicin 
contained an unknown impurity of 31% (molar mass 307 g/mol). In comparison, 
another batch of capsaicin (purity of 99%, Sigma-Aldrich, US) was analyzed to be 
96% (molar mass 305 g/mol).  
These data clearly demonstrate that dissolved capsaicin is stable under most 
experimental conditions including temperature and time. However, HPLC prior to use 
should check product purity of subsequent batches. 
  
 
 
 
 
 
 
 
 
#12 Carsten Faber 
 
Complement factor H lacks regulatory effects in retinal pigment epithelial cells 
 
Carsten Faber1, Jennifer Williams2, Helene Bæk Juel1, Stephen Moss2, Mogens Holst Nissen1, John 
Greenwood2 
1University of Copenhagen, Faculty of Health Sciences, Eye Research Unit, Copenhagen, 
Denmark; 2 Institute of Ophthalmology, University College London, London, United Kingdom 
 
 
Background: Age-related macular degeneration (AMD) is the most common cause of blindness in 
the western world, affecting more than 10% of persons above 60 years of age. Although the 
pathogenesis is not known in detail, it involves formation of drusen and degeneration of the retinal 
pigment epithelium (RPE).  
 
Age and a common variant of complement factor H (CFH) confer increased risk of developing 
AMD. The level of complement activation correlates to CFH haplotype, and AMD patients have 
elevated plasma concentrations of activation products such as C3a. Drusen contains many 
complement proteins including C3a.  
 
The objective of this study was to 1) examine the influence of age on expression of drusen-
associated genes in RPE cells and 2) examine whether this expression - especially complement 
encoding genes - depends on CFH. 
 
Methods: RPE/choroid was isolated from young (~50 days) and old (~500 days) WT and Cfh-/- 
C57Bl/6 mice immediately after killing. RNA from 2 eyes/animal, 4 animals/group, was isolated 
and analysed with GeneChip Mouse Gene 1.0 ST whole-transcript microarrays from Affymetrix. 
 
Results: Deficiency in CFH resulted in more than 2-fold change of 48 genes in young mice and 57 
genes in old mice. Age resulted in 207 genes changing in WT and 217 genes in Cfh-/- mice of 
which about 50% were common. Aging results in upregulation of several complement proteins 
including C1q, C3, factor B and Serping1. Though it is a major regulator of the alternative pathway, 
deficiency in CFH does not affect complement expression in RPE/choroid. 
 
Conclusions: Age has a great influence on gene regulation in RPE/choroid. Deficiency in CFH 
impacts age-related transcriptional changes, but has no local effect on complement factor-encoding 
genes. Increased expression of complement genes in RPE/choroid is an age-related phenomenon not 
directly related to CFH expression. 
#13 Sif Gudbrandsdottir 
Effects of activated human platelets on proliferation of PBMCs in vitro 
 
Gudbrandsdottir S1,2, Hasselbalch HC2, Nielsen CH1 
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Introduction 
Platelets are abundantly present in the circulation, and activated platelets may have a role in 
regulating immune responses. In this study we have examined how activated platelets influence the 
cytokine production and CD4+ T-cell proliferation elicited by self- and non-self antigens in cultures 
of mononuclear cells (MNCs) from healthy donors.  
 
Materials and methods 
MNCs were isolated from 7 healthy donors and labelled with carboxyfluorescein succinimidyl ester 
(CFSE). Platelets were isolated by centrifugation and activated by thrombin-receptor activating 
protein (TRAP). The MNCs were cultured in media containing autologous serum and stimulated 
with tetanus toxoid (TT), thyreoglobulin (Tg), autologous platelets (plts) or combinations of TT + 
plts or Tg + plts. Platelets were added to the cultures in concentrations ranging from 0.5 – 3.4 
x1010/L. Culture supernatants were harvested at day 1 and analysed for Th1/Th2 cytokine 
production. CD4+ T cell proliferation was measured at day 7 by flow cytometry. 
 
Results 
Addition of activated platelets caused an increased production of IL-10 in MNC cultures stimulated 
with Tg (p=0.016), but not in cultures stimulated with TT (p=0.938). Trends toward inhibited 
production of TNF-α elicited by Tg and IFN-γ by TT were observed in the presence of activated 
platelets. Moreover, activated platelets inhibited both the Tg- and the TT-induced proliferation of 
CD4+ cells (p=0.016 and p=0.047, respectively). 
 
Conclusion 
Addition of activated autologous platelets to MNC cultures increases the IL-10 production and 
inhibits the proliferation of CD4+ T cells elicited by the self-antigen Tg in vitro. Inhibition of the 
CD4+ T-cell proliferation elicited by TT was also observed. We are currently investigating the 
mechanisms behind these findings. 
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Maturation of dendritic cells for cancer immunotherapy employing novel 
cocktails and biodegradable, clinical-grade microparticles as delivery vehicle 
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Objectives 
The current standard protocol for maturation of dendritic cells (DCs) ex vivo for cancer 
immunotherapy employing TNF-α, IL-1β, IL-6 and PGE2 does not promote the production of IL-12 
and thereby does not polarize responders to a TH1 phenotype of relevance for generation of cancer-
specific cytotoxic T lymphocytes (CTLs). The aim of this project is to identify novel superior ways 
to induce immune competent mature DCs. 
 
The project is based upon two hypotheses 
• Microparticles, in particular poly(D,L-lactide-coglycolide) (PLGA), are clinically relevant 
vehicles for the ex-vivo co-delivery of protein-based antigens and danger-signals during 
manufacturing of immunogenic DCs from patient blood cells. 
• Phagocytosed antigens of non-microbial origin require co-delivery of “danger signals” (e.g. 
Toll-like receptor (TLR) ligands) in the same phagosome for efficient cross-presentation and 
generation of potent CTL responses. 
 
State-of-the-art in maturation of DCs  
IFN-α, IFN-γ, CD40 ligand, and/or TLR ligands have been included in cocktails for maturation of 
DCs to promote the production of IL-12. Recently it was shown that suppressed production of 
CCL19, preventing ligand-induced CCR7 internalization, is the key factor responsible for enhanced 
surface-CCR7 expression in DCs matured in the presence of PGE2 (Muthuswamy Blood 2010). 
Furthermore, in vivo studies did not demonstrate an advantage of PGE2-matured DCs in lymph-
node homing. Microparticle-based delivery of tumor-associated antigens (TAA) and maturation-
inducing molecules may potentially solve major issues of current DC-based cancer immunotherapy 
such as proper generation of both TAA-specific CD8+ CTLs and CD4+ TH1 cells. Such delivery 
platform may also facilitate more timely control of DC maturation and IL-12 production necessary 
for TH1 polarization of CD4+ T cells desirable for optimal anti-tumor immunity.  Studies from 
several groups generally find that PLGA microparticles are safe, non-activating vehicles that 
prolong antigen activation. Elamanchili et al encapsulated the LPS-analogue MPLA and showed 
enhanced TH1 promoting effects compared with soluble MPLA and Wischke et al. employed 
poly(I:C) coated PLGA microparticles for efficient DC maturation.   
 
Research plan 
• Identification of novel cocktails for DC maturation relevant for cancer immunotherapy 
• Characterization of PLGA microparticles with antigens and TLR ligands  
• Functional and phenotypic characterization of DCs  
• Adaptation of a clinically relevant DC vaccination protocol 
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Real-time, high-throughput measurements of peptide-MHC-I dissociation using 
a scintillation proximity assay 
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Efficient presentation of peptide-MHC class I complexes to immune T cells depends upon stable 
peptide-MHC class I interactions. Theoretically, determining the rate of dissociation of a peptide-
MHC class I complexes is straightforward; in practical terms, however, generating the accurate and 
closely timed data needed to determine the rate of dissociation is not simple. Ideally, one should use 
a homogenous assay involving an inexhaustible and label-free assay principle. Here, we present a 
homogenous, high-throughput peptide-MHC class I dissociation assay, which by and large fulfill 
these ideal requirements. To avoid labeling of the highly variable peptide, we labeled the invariant 
β2m and monitored its dissociation by a scintillation proximity assay, which has no separation steps 
and allows for real-time quantitative measurement of dissociation. Validating this work-around to 
create a virtually label-free assay, we showed that rates of peptide-MHC class I dissociation 
measured in this assay correlated well with rates of dissociation rates measured conventionally with 
labeled peptides. This assay can be used to measure the stability of any peptide-MHC Class I 
combination, it is reproducible and it is well suited for high-throughput screening. To exemplify 
this, we screened a panel of 384 high-affinity peptides binding to the MHC class I molecule, HLA-
A*02:01, and observed rates of dissociation that ranged from 0.1 hours to 46 hours depending on 
the peptide used. 
#16 Mikkel Harndahl 
Immunogenic CTL epitopes tend to be stably bound to MHC class I molecules: 
Implications for “holes in the stably bound MHC-I repertoire” 
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Morten Nielsen2, Søren Buus1 
1 Laboratory of Experimental Immunology, Faculty of Health Sciences, University of Copenhagen, 
Denmark; 2 Center for Biological Sequence Analysis, Department of Systems Biology, Technical 
University of Denmark, Denmark 
 
Efficient presentation of peptide-MHC-I (pMHC-I) complexes to immune T cells should benefit 
from a stable peptide-MHC-I interaction. However, it has been difficult to distinguish stability from 
other requirements for MHC-I binding. We have recently established a high-throughput assay for 
peptide-MHC-I stability. Here, we have used this assay to generate a large database containing 
stability measurements of pMHC-I complexes, and we re-examined a previously reported unbiased 
analysis of the relative contributions of antigen processing and presentation in defining CTL 
immunogenicity (Assarsson, Sidney et al. 2007). Using an affinity-balanced approach, we 
demonstrated that immunogenic peptides are more likely to be stably bound to MHC- I molecules 
than non-immunogenic. To predict pMHC-I stabilities, we here developed a bioinformatics method 
based on our pMHC-I stability data. This predictor suggested that 30% of the non-immunogenic 
binders that hitherto have been classified as “holes in the T cell repertoire” can be explained as 
being unstably bound to MHC-I. Finally, we suggest that non-optimal anchor residues in position 2 
of the peptide are particularly prone to cause unstable interactions with MHCI. We conclude that 
the availability of accurate predictors of pMHC-I stability may be helpful in the elucidation of 
MHC-I restricted antigen presentation, and that it may be instrumental in future search strategies for 
MHC-I epitopes. 
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Treatment with interferon-beta (IFN-beta) is standard therapy in multiple sclerosis (MS).  
To investigate whether IFN-beta therapy affects the circulating levels of B-cell activating factor of 
the TNF family (BAFF) and autoantibodies against myelin basic protein (MBP) we followed 23 
patients with relapsing-remitting MS (RRMS) longitudinally from initiation of IFN-beta therapy. 
Their blood levels of BAFF correlated positively at baseline with the expanded disability status 
scale (P<0.009) and MS severity score (P<0.05), but not with disease activity as determined by the 
number of gadolinium-enhanced lesions. A second group of 26 patients with RRMS were followed 
for up to 26 months, during which the BAFF levels remained increased without being associated 
with increased disease activity. IFN-beta therapy caused an increase in plasma BAFF levels after 
both 3 and 6 months of therapy (P<0.002), but an 11% decrease in IgM- and a 33% decrease in IgG 
anti-MBP autoantibodies (P<0.09 and P<0.009, respectively) after 6 months. The increased 
circulating BAFF levels during IFN-beta therapy do not have detrimental effects in terms of 
increased disease activity, and does not translate into increased levels of anti-MBP autoantibodies, 
in line with the known beneficial effect of IFN-beta treatment. 
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Vaccination against lymphocytic choriomeningitis virus infection in MHC class 
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The impact of prophylactic vaccination against acute and chronic infection in a T helper deficient 
host has not been adequately addressed due to difficulties in generating protective immunity in the 
absence of CD4+ T cell help. In this study we demonstrate that a broad CD8+ T cell immune 
response can be elicited in MHC class II deficient mice by vaccination with adenovirus encoding 
LCMV3 glycoprotein4 tethered to MHC class II associated Invariant chain (Ad-IiGP5). Moreover, 
the Ad-IiGP induced response confers significant cytolytic CD8+ T-cell mediated protection against 
challenge with the invasive clone 13 strain of LCMV. In contrast, vaccination with adenovirus 
encoding unlinked LCMV GP induced marginal virus control in the absence of CD4+ T cells, and 
mice may die from increased immunopathology associated with incomplete protection. Following 
infection with the less invasive Traub strain, no acute mortality was observed in any vaccinated 
mice. However, LCMV Traub infection caused accelerated late mortality in unvaccinated MHC 
class II deficient mice, and in this case we observed a strong trend towards delayed mortality in 
vaccinated mice irrespective of the nature of the vaccine. These results indicate that optimized 
vaccination may lead to efficient protection against acute viral infection even in T helper deficient 
individuals, but that the duration of such immunity is limited. 
 
#19 Tina Jehs 
 
The effect on T-cell derived cytokines on astrocyte cultures 
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Background: With age low-grade chronic inflammation becomes more prominent with increasing 
plasma concentration of proinflammatory cytokines primarily due to rearrangement of the T- cell 
compartment. Since astrocytes form part of the blood brain barrier and they play a central role in 
maintaining the homeostasis within the CNS, we want to investigate whether there may be a 
correlation between age-related changes in the immune system, astrocytes and the development of 
age-related neurodegenerative diseases such as Alzheimer´s disease (AD). 
 
Methods and results: PBMCs were purified from healthy human donors, activated with CD3/CD28 
beads, and co-cultured with human astrocytoma cell lines. This co-culture was performed by 
inserting a membrane between activated PBMCs and astrocytes so only soluble factors can pass. 
Microarray analysis of astrocytes showed induction of a great number of genes after co-cultured 
with activated PBMCs. Among these genes were pro-inflammatory cytokines and chemokines such 
as IL6, IL8, IL1β, CXCL10 and CCL5. Additionally the up-regulation of CXCL9, CXCL10, IL8, 
CCL3, CCL5, IL1β and IL6 was validated on protein level by luminex. 
 
Conclusion: Cytokines derived from activated PBMCs affect the astrocytes transcriptome towards a 
more activated state including upregulation of IL6 and IL1β. Both activated astrocytes and 
overexpression of IL6 and IL1β have been associated with AD. Thus increased levels of plasma 
derived cytokines might have a role in AD pathogenesis. 
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Recombinant adenoviral vectors are among the most potent and versatile antigen delivery vehicles 
available. By tethering the vaccine antigen to the MHC class II associated Invariant chain (Ii) we 
have previously increased both the potency and the versatility. 
The aim of this project is to investigate the potential of endogenous IL-2 production in antigen 
presenting cells, presenting endogenous antigen to CD8+ T-cells selectively or to both CD8+ and 
CD4+ T-cells. For that purpose we have constructed replication deficient adenoviral vaccine vectors 
(Ad) expressing the Lymphocytic Choriomeningitis virus (LCMV) Glycoprotein (GP) with and 
without linkage to Ii in the adenoviral E1 reading frame, and with and without an IL-2 expression 
cassette in the E3 reading frame.  
 
The IL-2 encoding vectors have been confirmed to secrete biologically active IL-2.  
The Ad-GP construct is known to induce a rather weak, narrow and slow response, which can be 
dramatically augmented by the linkage of the antigen to Ii. We are testing whether additional IL-2 
expression can increase it further. 
 
The kinetics, breadth and stability of the antigen specific response will be determined by measuring 
IFN-γ producing CD8+ and CD4+ T-cells at different time points (7, 11, 14, 21 , and 60-90 days 
post vaccination). The potency of the constructs will be determined by dose/response experiments, 
where the immune responses are measured at early and late time points. 
 
To determine the quality of the memory response we will investigate the expression of surface 
markers such as KLGR-1, CD27, CD127, CD43, CXCR3 and CD62L on the antigen specific T-
cells and the ability of the elicited T-cells to co-produce multiple cytokines such as IFN-γ, TNF-α 
and IL-2. Finally, the ability of the induced T-cells to expand in response to infection will be 
assessed by adoptive transfer into naive hosts which are then challenged by LCMV. 
 
The outlined experiments should form the basis of an initial characterization of the vaccines’ 
capabilities in wild type mice, and make the basis for further characterization in immunodeficient 
hosts such as CD80/CD86 and MHC-II deficient animals.  
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Investigation of the cancer resistant phenotype of the SR/CR mouse 
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The SR/CR mouse (Spontaneous Regression/Complete Resistance) model of cancer resistance was 
discovered in 1999. It is resistant to a number of different cancer cell lines and the heritable 
phenotype was demonstrated on different genetic backgrounds. The cancer resistance is transferable 
to other strains of mice by adoptive transfer of innate immune cells. We for the first time, confirm 
the findings of the SR/CR phenotype of cancer resistance to the S180 sarcoma cell line in mice of 
two different genetic backgrounds: BALB/c and C57BL/6.  
 
FACS profiles of peritoneal cells from SR/CR mice and wild type mice 48 hours after 
intraperitoneal injection of S180 cells reveal large morphological differences: In the wild type mice 
a large population of the large granulated S180 cells is recognised, while this population is nearly 
absent in the SR/CR mice. The amount of infiltrating immune cells is also markedly larger in the 
SR/CR mice. Interestingly the SR/CR mouse has significantly higher proportions of neutrophils, 
macrophages and NK cells compared to wild type mice, while the proportion of CD19 positive cells 
is significantly higher in wild type mice. In FACS analysis of the splenocytes of SR/CR mice after 
stimulation with S180 cells there are also significantly increased levels of neutrophils, macrophages 
and NK cells, compared to the splenocytes in wild type mice injected with S180 cells at the same 
time.  
 
Adoptive transfer of immune cells from SR/CR mice to wild type mice with subcutaneous S180 cell 
tumours have resulted in complete regression of the tumours. In histology sections of the regressing 
tumours large areas with necrosis and infiltrating neutrophils are found.  
The SR/CR mouse thus shows a unique ability to kill even large populations of injected cancer 
cells, and this resistance to cancer cells seems to be mediated by the innate immune system. 
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The literature describes an important role for vitamin D in the function of the immune system. The 
vitamin D receptor (VDR) is expressed in activated but not in naïve human T cells. Vitamin D 
interacts with the VDR in the cytosol of T cells, leading to the translocation of the vitamin D-VDR 
complex into the nucleus where it acts as a transcription factor for various genes controlling T cell 
function. Vitamin D circulates in the blood mainly as the inactive mono-hydroxylated precursor 
(25(OH)D3). In order to become biologically active, a second hydroxylation must occur 
(1,25(OH)2D3). This hydroxylation step is catalyzed by the enzyme CYP27B1 found in the kidneys. 
In the present study we show that naïve human primary T cells express low levels of CYP27B1 and 
that CYP27B1 expression is greatly upregulated during T cell activation, an upregulation that 
precedes VDR upregulation. In the blood, vitamin D is bound to vitamin D binding protein (DBP). 
For vitamin D to be taken up by kidney cells, vitamin D-DBP binds to the receptor megalin leading 
to receptor-mediated endocytosis of the complex. We find that megalin is expressed by both naïve 
and activated T cells, and that megalin expression is up-regulated following T cell activation. 
Altogether, this study shows an increased capacity of activated human T cells to internalize vitamin 
and convert it into its metabolic active form.  
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Large scale T cell epitope discovery in yellow fever virus 
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This project involves a comprehensive, large-scale discovery effort directed at identifying T cell 
epitopes targeted in the acute immune response following vaccination with attenuated yellow fever 
(YF) virus in an out bred population of vaccinees. YF is an acute viral hemorrhagic disease and 
is transmitted by mosquitos (the yellow fever mosquito, Aedes aegypti, and other species) and is 
found in tropical and subtropical areas in South America and Africa. YF is on the NIAID list of 
“Biodefense Category A, B, C Pathogens” as one of the emerging infectious diseases (i.e. Category 
C). The YF vaccine is a live attenuated virus. It is therefore an ideal system for T cell epitope 
discovery: the vaccine itself is extremely safe; vaccinees are regularly and easily accessible due to 
the frequent and widespread use of the YF vaccine; and the strength of the ensuring T cell immune 
responses allow easy ex vivo monitoring of T cell responses. Volunteers donate blood before and 
about 2 weeks after vaccination. For comparison both pre-and post PBMCs from the vaccinees will 
initially be analyzed using multicolor flowcytometry to determine the frequency of activated T cells 
using intracellular phenotypic markers (e.g. CD4, CD8, KI-67, Bcl-2 and CD38) and surface 
markers (e.g. CD4, CD8, HLA-DR, CD45RA, CCR5, CCR7, CD27 and CD57. We will screen for 
specific T cell responses against the entire YF proteome (an effort involving a mere ≈ 900 
overlapping peptides), and attempt to identify all peptide-specific, HLA-restricted T cell responses 
arising in vaccinees using ELIspot analysis with a 30x30 peptide matrix. Identified peptide epitopes 
will be validated using multicolor flowcytometry to determine the nature of the YF specific T cell 
response (phenotypic markers e.g. CD4, CD8 and CD38, functional markers such as IFNγ and 
TNFα and specificity markers (e.g. HLA tetramers)). Sera from donors will also be analyzed for YF 
specific antibodies using ELISA. 
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Cancer often originates from sites of persistent inflammation whereas the mechanisms turning 
chronic inflammation into a driving force of carcinogenesis are not completely understood. 
Cyclooxygenase-2 (COX-2) is an inducible key modulator of inflammation that carries out the rate-
limiting step in prostaglandin synthesis. Aberrant COX-2 expression as well as induction of 
prostaglandin E synthase 1 (PGES1) and prostaglandin E2 (PGE2) production have been implicated 
in the pathogenesis of several cancer types. Chronic inflammation is a hallmark of cutaneous T cell 
lymphoma (CTCL). The most common form, mycosis fungoides (MF), is a lymphoproliferative 
disorder which in early stages (patch stage) resembles chronic inflammatory dermatitis. In the later 
stages (plaque, tumor stage) skin tumors form and malignant cells spread to extracutaneous sites. 
We show that COX-2 is ectopically expressed in malignant, but not in non-malignant T cell lines 
from patients with CTCL as well as in situ in lymphoma cells in 11 out of 22 patients suffering 
from MF in plaque or tumor stage. COX-2 is not expressed in lymphocytes of patients with patch 
stage MF; however, COX-2 positive stroma cells are detectable in the majority of patients 
regardless of disease state. COX-2 expression correlates with a constitutive production of PGE2 in 
malignant T cells in vitro. These cells express PGE2 receptors EP3 and EP4 as well as PGES1 and 
spontaneous proliferation is strongly reduced by the receptor antagonist and PGES inhibitors. 
Furthermore, malignant cell growth is heavily decreased by COX-2 inhibitors and siRNA directed 
against COX-2. Our data indicate that COX-2 mediated PGE2 acts as a tumor growth factor in MF. 
We propose COX-2 and downstream players of PGE2 synthesis as novel therapeutic targets in 
CTCL. 
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Induction of T-cell responses to a self-antigen, thyroglobulin, by B cells  
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In addition to being antibody-producing, B cells are highly efficient at antigen-presentation as well 
as cytokine production. We investigated the responses of normal mononuclear cells (MNCs) to the 
self-antigen thyroglobulin (TG) and observed a significant production of IL-6, TNF-α, IL-10 and 
IL-2, as well as CD4+ T-helper (TH) cell proliferation. Depletion of monocytes from the cultures 
abrogated these events, while depletion of B cells caused non-significant inhibitions, showing that 
monocytes were the more efficient APCs. However, B cells pulsed with TG induced a significant 
production of TNF-α, IL-6, IL-2 and considerable amounts of IL-10 upon co-culture with purified T 
cells. An induced TH-cell proliferation was also seen. B cells pulsed with the foreign recall antigen, 
tetanus toxoid, induced a different cytokine profile including IFN-γ and IL-2, but almost no IL-10. 
Moreover, the subsequent TH-cell proliferation was higher than that induced by TG-pulsed B cells. 
Staining with bi-specific anti-CD45/anti-cytokine antibodies revealed that 11% of the TH cells 
produced IL-10 in the presence of B cells pulsed with TG, compared with 1% in presence of 
unpulsed B cells (p<0.03). At this time point, IL-10 producing B-/T-cell aggregates were observed. 
At day 7, IL-10 was produced by 4% of the TH cells, primarily within the proliferating subset. Thus, 
despite the observation that monocytes are the dominant APCs in APC cultures, B cells are capable 
of inducing TNF-α-, IL-6- and IL-10 production by, and proliferation of, T cells in the absence of 
monocytes, which is likely to reflect the conditions in lymph nodes.  
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Background: Probiotics may alter immune regulation. Recently we showed that the probiotic 
bacteria Lactobacillus acidophilus NCFM™ influenced the activity of regulatory T cells (Tregs) in 
vitro. The aim of the present work was to demonstrate if Lactobacillus acidophilus NCFM™ also 
affects the function of Tregs in vivo.  
Methods: Development of colitis after transfer of CD4+CD25- T cells and protection from colitis 
by Tregs was studied in immunodeficient SCID mice which were simultaneously tube fed with L. 
acidophilus NCFM™ or L. salivarius Ls-33  or water (control) for 5 weeks. Changes in gene 
expression related to inflammation and autoimmunity in rectum of protected mice was compared 
with naïve mice. 
Results: Probiotic fed SCID mice transplanted with low numbers of Tregs in addition to the disease-
inducing T cells were completely protected from colitis. This was in contrast to the control group 
that showed intermediate levels of inflammation. In addition, feeding with probiotics lowered serum 
levels of inflammatory cytokines in both colitic mice and in mice protected from colitis by Tregs. 
Gene expression patterns of rectum samples of protected mice that receive either one of the 
probiotics showed a closer resemblance to naïve SCID mice than did patterns of the control group. 
Enteroantigen specific T cells from mesenteric lymph nodes of L. acidophilus NCFM™ fed 
protected mice showed an upregulation of Th2 cytokines compared to the other groups.  
Conclusion: L. acidophilus NCFM™ and L. salivarius Ls-33 feeding of SCID mice increases the in 
vivo effect of Tregs, resulting in a phenotype resembling that of the naive SCID mouse. 
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Psoriasis represents a chronic inflammatory skin disease with an approximate prevalence of 
more than 2 % of adults in the Western population. Today psoriasis is considered to be an 
autoimmune disease with skin manifestations. MicroRNAs (miRNAs) are a class of 
posttranscriptional regulators of gene expression with critical functions in health and disease. 
We have recently identified a specific miRNA expression-profile in psoriatic skin that differs 
from normal skin. Here we hypothesize, that the miRNA expression-profile in blood from 
patients with psoriasis may reflect chronic systemic disease with involvement of skin. Thus, 
the overall aim of this project is to identify specific biomarkers in blood from patients with 
psoriasis. We plan to identify miRNA and messenger RNA (mRNA) expression-profiles in the 
blood from patients with psoriasis and compare these profiles with profiles previously 
identified in psoriatic skin. Furthermore, we plan to examine biomarker profiles in relation to 
comorbidities and treatment response. The importance of relevant miRNAs and their potential 
target mRNAs will be examined and validated in vitro and in vivo. We hope that the 
identification of systemic biomarker profiles in patients with psoriasis will improve our disease 
understanding. Additionally, the use of miRNAs as biomarkers in this complex disease may 
lead to the identification of new potential targets for therapies. 
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Whole bacteria can stimulate the immune response in various ways. We live in symbiosis with an 
extremely high number of bacteria. Many factors determine whether bacteria can be beneficial or 
harmful to human health. These include timing, dosage and virulence factors of the bacterium.  
In this study, we used bone marrow derived dendritic cells from mice to study the immune 
stimulating effects of a whole new array of microbes; bacteria of marine origin. In a time of 
continuous search for beneficial microorganism on human health e.g. towards chronic inflammation 
of the gut, we ask, if this unexploited resource of bacteria could show novel or improving functions 
on the immune system.  
 
So far, it has been seen that, dependent on the strain of marine bacteria, it can induce different 
immune responses. We found that bacteria from both the Ruegeria and Phaeobacter genus were 
able to induce high IL-12 production in dendritic cells, indicating a directed TH1 response for the 
Ruegeria and Phaeobacter. Some bacteria from the Pseudoalteromonas genus were not able to 
induce an IL-12 response in dendritic cells. The cause of the low immune response induced by 
some Pseudoalteromonas is under investigation. Especially the high production of 
exopolysaccharides in these strains is considered to impact the immune response. Preliminary 
results indicate that the exopolysaccharides decrease the pro-inflammatory response otherwise 
induced by the lipopolysaccharides of these Pseudoalteromonas strains.  
 
#29 Caroline B. Madsen 
 
A MUC1-derived peptide elicits MUC1 specific antibodies and CD8 T cells in 
HLA-A2 transgenic mice 
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Background: MUC1 is a glycoprotein highly overexpressed in the majority of human 
adenocarcinomas. MUC1 contains multiple tandem repeats carrying O-linked glycans, which are 
incompletely glycosylated in cancer resulting in presentation of short tumor-associated 
carbohydrate antigens. Several MUC1-derived peptides that map outside the tandem repeat 
domainand comply with the peptide-binding-motif for HLA-A*0201 is also known, one such 
peptide being DegMUC1. In the search for a vaccine, which induce both antibodies and cytotoxic 
T-cells we have investigated the humoral and cellular immune response to DegMUC1 with and 
without O-linked glycans.  
 
Methods: Balb/c and HLA-A*0201 mice were immunized with peptides with and without 
glycosylation. Responses were monitored by flow cytometry, proliferation assay, and ELISA. The 
significance of glycosylation on peptide processing and MHC I presentation was monitored 
indirectly by SIINFEKL-DegMUC1 fusion peptide experiments.  
 
Results: MUC1 specific IgG antibodies were elicited in Balb/c and HLA-A2 mice and DegMUC1 
elicited cellular responses in both mouse strains. Glycosylation enhanced the response in Balb/c 
mice but blocked CD8-response in HLA-A2 mice. We assessed the significance of glycosylation on 
the uptake, presentation, and CD8 T-cell stimulation of MUC1-derived peptides in vitro, using 
DegMUC1- SIINFEKL fusion peptides. This demonstrated that O-glycosylation inhibits the 
processing and/or presentation of DegMUC1 peptide and thereby CD8 T-cell activation.  
 
Conclusion: Glycosylation leads to enhanced cancer specific humoral immunresponse while 
blocking the CD8 T cell response to DegMUC1.  
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Hepatitis C virus (HCV) currently infects ~180 million people worldwide. No vaccine exists, and 
the lack of appropriate cell culture systems, from which HCV particles could be purified has until 
recently prevented studies of the possibility of developing whole virus inactivated vaccine 
candidates. Recombinant HCV grown in cell culture (HCVcc) has been shown to consist of a 
heterogeneous population in regard to physiochemical properties as determined in density gradient 
analysis. Therefore, the purification of HCVcc from FBS derived components present in 
conventional DMEM has proven difficult using traditional methods such as ultracentrifugation. In 
an attempt to solve this problem, we harvested HCVcc from cells kept in a serum-free medium 
(AEM). The peak infectivity titers of the serum-free HCVcc (sf-HCVcc) particles could easily be 
determined and was similar to those of HCVcc. To further characterize sf-HCVcc we analyzed the 
density profile of the infectious particles and saw a shift from a heterogeneous HCVcc population to 
a single-peak homogenous sf-HCVcc population. The kinetics of this shift seemed to be genotype 
dependent, as HCVcc of a genotype 5a isolate shifted more rapidly than that of a genotype 2a 
isolate. We also tested the ability of sf-HCVcc to infect target cells with or without presence of 
FBS. Sf-HCVcc diluted in AEM was less infectious than HCVcc diluted in complete DMEM, at the 
same multiplicity of infection. Finally we tested the stability of sf-HCVcc. Storage of sf-HCVcc at 
4°C induced a loss of infectivity of ~50%. This loss was not observed with HCVcc. Our results 
demonstrate that HCVcc associates with FBS components, and this association seems to be required 
for proper infectivity as well as stability of the virus particles. Understanding the physiochemical 
properties of sf-HCVcc may prove important for the production of a HCV antigen to be used in 
future vaccine candidates. 
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A central issue in vaccinating against viral infections is the induction of a CD8 T cell response. 
DNA vaccines are safe and have been shown to stimulate such responses; still the responses are 
inefficient and so far no clinical trial has demonstrated sufficient protection in humans. It has 
previously been established that linking invariant chain (Ii) to certain DNA vaccine antigens will 
improve adenovectored DNA vaccines in terms of duration, time of onset, breadth and CD8 T cell 
quality. However, this effect was not seen when Ii was linked to the highly potent NP gene of 
LCMV.  
 
The first part of this study aims to investigate whether the benefits of linking Ii to the antigen is 
restricted to specific antigens, or if it will improve the quality of the NP vaccine under certain 
conditions such as reduced vaccine loads, prolonged incubation period, and lack of co stimulatory 
signals. Furthermore, the quality of the induced CD8 T cell response will be investigated in terms of 
differential cytokine production. 
 
The second section of the project concerns vaccination with the two GP mutants, GPNoB and 
GPTCR, carrying a dominant epitope which cannot bind MHC class I and TCR, respectively. The 
aim of this part is to describe how Ii interferes with the T cell competition and cooperation by 
describing if Ii assists the subdominant epitopes in propagating an immune response sufficient for 
protection against subsequent viral infection. 
 
Thus, this study aims to describe the possibilities and limitations of Ii-linking and will illustrate 
perspectives for a potential future vaccine for humans. 
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Interplay between monocytes and regulatory T cells in relation to interleukin-10 
production 
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An imbalance in cytokine homeostasis is involved in the pathogenesis of autoimmune diseases. The 
anti-inflammatory cytokine interleukin (IL)-10 plays a major role in down-regulating immune 
responses to self-antigens, and has been shown to delay or prevent the onset of autoimmune disease 
in experimental animal models. IL-10 is produced by inducible regulatory T cells (iTregs or Tr1) 
and B cells, but the major reservoir of IL-10 in the circulation is associated with monocytes.  
Our previous work shows that the self-antigen thyroglobulin (TG) induces proliferation of normal 
CD4+ T-helper cells, and that the outcome of this stimulation is a relatively high production of IL-
10, as compared to stimulation with foreign antigens. IL-10 was produced by a minor subset of 
memory CD4+CD4R0+ T cells and by the bulk of monocytes. However, depletion of T cells as 
well as of monocytes abrogated the IL-10 production, suggesting that it involves interplay between 
the two cell types. We therefore hypothesize that a positive feedback system exists, in which IL-10 
production by iTregs regulates the release of larger quantities of IL-10 by monocytes. Moreover, 
IL-10 may activate the IL-10 receptor on monocytes in an autocrine manner, creating a positive 
feed-back loop.  
 
The interaction between iTregs and monocytes in relation to IL-10 production induced by self-
antigens will be studies by antibody-mediated blockade of the IL-10 receptor on either cell type, 
knock-down of IL-10 production by either cell type using siRNA, and by addition of exogenous IL-
10 to cultures of purified monocytes or T cells. Moreover, antibodies blocking MHC II will be used 
to determine whether inter-cellular IL-10 signalling is associated with antigen-presentation. 
Production and secretion of IL-10 will be assessed by intracellular staining and Luminex 
technology, respectively.  
 
Advanced understanding of the role of IL-10 in autoimmune diseases and how to regulate its 
production may have therapeutic implications. 
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Tapasin binds and integrates the MHC-I molecule into the peptide-loading complex (PLC) where it 
exerts quality control of the peptide – MHC-I complex and retains it in the ER until an optimal 
peptide is bound to the MHC-I. The exact mechanism by which tapasin exerts this quality control is 
still unknown. Here, we show that the first 87 residues of tapasin, Tpn1-87 facilitates folding of 
peptide – MHC-I complexes both in a peptide and HLA-I molacule dependent manner. Tpn1-87 
facilitates the folding of peptide – MHC-I complexes with HLA-A*02:01, HLA-B*08:01 and HLA-
B*44:02 but not the tapasin-independent HLA-B*27:05 or the HLA-A*02:01-T134K mutant 
molecule. The stabilities of several peptide – HLA-A*02:01 complexes were measured and the 
degree of Tpn1-87 facilitation of peptide – HLA-A*02:01 complexes inversely correlated with their 
intrinsic stabilities. The stability of peptide – HLA-A*02:01 complexes loaded with immunogenic 
peptides were higher than for those loaded with non-immunogenic peptides. Hence, Tpn1-87 can be 
used to discriminate immunogenic from non-immunogenic peptides. 
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Minor histocompatibility antigens (mHags) were originally identified as antigens causing graft 
rejection or graft-versus-host disease in otherwise HLA-matched recipients following allogeneic 
hematopoietic cell transplantation (HCT) due to leukaemia or other haematological malignancies. 
 
mHags are allelic variants of non-MHC genes that leads to protein polymorphism and can be either 
non-synonymous single nucleotide polymorphisms or HY-antigens which are disparities between 
male vs. female specific variants of homologous genes (Y/X-polymorphism). 
 
In connection with HCT for the treatment of leukaemia, mHags could be utilized as targets for 
immunotherapy if T cells specific for mHags solely expressed in hematopoietic cells could be 
generated, expanded and adoptively transferred to the patient as a donor lymphocyte infusion 
leading to a highly desirable graft-versus-leukaemia effect eradicating any residual leukemic cells in 
the patient. 
 
Having a large panel of mHags to choose from when selecting donors for a given recipient should 
allow for donor selections leading to better anti-tumor effects and reduced side-effects, however, at 
this time only very few minors are known. 
 
In order to identify novel mHags approximately 200 HCT donor/recipient pairs have been analyzed 
with regards to their mHag disparities. MHC class I binding peptide epitopes from the differentially 
expressed proteins have been predicted using a predicting algorithm available at 
http://www.cbs.dtu.dk/services/.  
 
mHags with predicted MHC class I binding have been synthesized as peptides with a length of 8-11 
amino acids. The immunogenicity of these peptide epitopes will be examined in vitro in T cell 
cultures and the binding of the epitope to MHC class I molecules will be validated in MHC-peptide 
binding assays. 
 
So far, T cells from 8 female-donor/male-recipients obtained from blood samples drawn 3 months 
to 8 years post transplant have been stimulated with their putative mHag epitopes in T-cell 
stimulation assays and analysed for T cell reactivity by flow cytometry using intracellular cytokine 
staining. 
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Background 
Around 20% of people in the western part of the world suffer from diseases connected to autoimmunity. 
While the cause of this is still elusive, it is clear that autoimmunity is associated with loss of immunological 
tolerance, which is the ability of an individual to ignore 'self' and still react to 'non-self'. This breakage leads 
to an effective and specific immune response against self determinants.  
Blocking of inflammatory cytokines, primarily TNF-alpha, has recently nearly revolutionized the treatment 
of e.g. rheumatoid arthritis. Moreover, recent advances in blocking of cytokine production driving 
differentiation of CD4 T cells into autoimmune Th17 effector cells such as IL-23/IL-12 p40 mAb have an 
impressive effect in the treatment of arthritis and psoriasis. Thus affecting the culprit of the autoimmune 
inflammation, the controlling CD4 T lymphocytes, is likely an even more effective and specific treatment 
rationale for autoimmune disorders. 
Patients with rheumatoid arthritis (RA) are characterized by an unusual population of CD4+ CD28- 
NKG2D+ lymphocytes. Several studies have now shown that autoreactive lymphocytes bear resemblance 
with senescent lymphocytes, that down-regulate costimulatory CD28, concomitant with up-regulating of 
costimulatory molecules with a more broad reactivity range. An emerging hypothesis is that autoimmunity, 
which normally occurs later in life, is significantly influenced by the broad activation potential of senescent 
cells. 
 
Objectives 
The objective of my study is to characterize surface molecules that are critical for autoimmune activation of 
CD4 T lymphocytes during RA or psoriatic arthritis, including examination of the mechanism that leads their 
increased surface expression. Currently, the project focuses on characterizing the involvement of the TNF-
receptor ligand TL1A in RA inflammation, but it is the intention to screen for new factors involved in RA 
inflammation. Also, I will investigate how CD4 T lymphocytes are affected by stimulation through TL1A 
and other molecules, in terms of production of new cytokines, surface molecules and regulation of growth 
and apoptosis. 
 
Finally, I will investigate if blocking TL1A or other identified receptor / ligand interactions will affect 
experimental models of autoimmunity, primarily collagen-induced arthritis in DBA/1 mice. This part will be 
conducted in collaboration with section for animal models at Leo Pharma. 
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Previously, RNA transcripts of cDNA clones of hepatitis C virus (HCV) genotypes 1 and 2 were 
found to be infectious in chimpanzees. However, only the genotype 2a strain JFH1 was infectious in 
human hepatoma Huh7 cells. We performed genetic analysis of HCV genotype 3a and 4a prototype 
strains, and generated full-length consensus cDNA clones. Transfection of Huh7.5 cells with RNA 
transcripts of these clones did not yield HCV Core expressing cells. However, intrahepatic 
transfection of chimpanzees resulted in robust infection with peak HCV RNA titers of ~5.5 log10 
IU/mL. Genomic consensus sequences recovered from serum at time points of peak viral titers were 
identical to the parental plasmids. Both chimpanzees developed acute hepatitis with elevated liver 
enzymes and significant necro-inflammatory liver changes coinciding with detection of interferon-γ 
secreting, intrahepatic T cells. However, onset and broadness of intrahepatic T-cell responses varied 
greatly in the two animals, with an early (week 4) multi-specific response in the 4a infected animal 
(three weeks before first evidence of viral control), and a late (week 11) response with limited 
breadth in the 3a infected animal (without evidence of viral control). Autologous serum neutralizing 
antibodies were not detected during the acute infection in either animal. Both animals became 
persistently infected. In conclusion, we generated fully functional infectious cDNA clones of HCV 
genotypes 3a and 4a. Proof of functionality of all genes might further the development of 
recombinant cell culture systems for these important genotypes.  
 
#37 Esben Schmidt 
 
Enteroantigen-presenting B cells efficiently stimulate CD4+ T cells in vitro 
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Background: Presentation of enterobacterial antigens by antigen presenting cells and activation of 
enteroantigen-specific CD4+ T cells are considered crucial steps in IBD pathology. The detrimental 
effects of such CD4+ T cells have been thoroughly demonstrated in models of colitis. Also, we have 
previously established an in vitro assay where murine enteroantigen-specific colitogenic 
CD4+CD25- T cells are activated by splenocytes pulsed with an enterobacterial extract. 
Methods: CD4+CD25- T cells were stimulated in vitro with various kinds of enterobacterial extract-
pulsed antigen presenting cells. T helper phenotypes were detected by flow cytometry. 
Results: We found that enteroantigen-pulsed splenic B cells possess a significantly higher and more 
sustained T cell stimulatory capacity than similarly pulsed splenic dendritic cells (DCs) measured 
by the level of enteroantigen-specific CD4+CD25- T cell proliferation. In support of this, we 
observed upregulation of classic maturation markers in B cells following incubation with 
enterobacterial antigens. Peritoneal and mesenteric lymph node-derived B cells were equally 
effective as enteroantigen-presenting stimulator cells. B cells greatly expanded the number of 
stimulated CD4+ T cells, which acquired a TH2 phenotype. Interestingly, regulatory T cells were 
primarily activated by enteroantigen-pulsed B cells but not by similarly pulsed DCs. 
Conclusions: We conclude that B cells are superior stimulators of enteroantigen-specific CD4+ T 
cells in vitro, favoring TH2 polarization. Thus, enteroantigen-processing and -presentation by B 
cells instead of by DCs might have opposing consequences for IBD development. 
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Treatment of cancer by vaccination is not a new idea, but we are still far from having vaccines that 
effectively eliminate established tumours. 
 
At present time, our laboratory has successfully prolonged the life of tumour-bearing animals by 
vaccination with an adenovirus vector (Ad5) encoding an exogenous tumour-associated antigen. 
However, the immune response wanes over time, and eventually the tumour starts growing out 
again. It is therefore relevant to investigate whether the tumour-specific immune response can be 
sustained through repeated immunizations.  
 
In our lab, we are using an optimized adenoviral vaccine system with a vector (Ad5) encoding the 
glycoprotein of LCMV tethered to the invariant chain (IiGP). Following vaccination with this 
vector, we initially see an inhibitory effect on the ability of the vector to re-induce an immune 
response upon a second immunization. However, 6 months after vaccination, the inhibition is 
markedly reduced, and it is again possible to induce an immune response against the antigen using 
the same vector. 
 
The short term inhibition can be transferred by serum and is absent in B cell deficient mice, 
indicating that neutralizing antibodies are the main mediators of this effect. 
This result was also supported by neutralization assays showing 50% neutralization of virus 
particles at a serum dilution of 1:80. 
 
To overcome this immunity, we have inserted IiGP into the Ad35 vector, which belongs to another 
subgroup of adenoviruses and therefore, is not neutralized by antibodies directed towards the Ad5 
vector. At present time, the Ad35 vector has been tested in mice with a positive result, and prime-
boost regimes using the Ad35 and Ad5 vectors have been performed, resulting in an effective 
boosting of the immune response. 
  
Homologous and heterologous prime-boost regimes are being tested in tumour-bearing animals to 
evaluate their ability to induce an effective and long lasting immune response against a growing 
tumour. To this end, we also intend to test these regimes in CD46 transgenic mice, since CD46 is a 
receptor for Ad35 that is expressed on all nucleated cells in humans, but not in mice. Furthermore, 
CD46 expression is up-regulated on human tumours making Ad35 very attractive for tumour 
therapy. 
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Background: The B16.F10 melanoma model is a well described murine model for human cancer, 
which is widely used in the research of tumor immunology and in the testing of a variety of anti-
cancer vaccine strategies. The B16.F10 cell line can be used in a solid tumor model, in which the 
B16 cells are injected subcutaneously leading to the formation of a solid tumor. The growth of the 
tumor can then be measured using a dial caliper. Another way to use this cell line is by intravenous 
administration of the B16.F10 cells, leading to the formation of lung metastases, as the B16.F10 cell 
line has been selected for invasion of the lungs. Metastases can then be counted after several days, 
depending on the initial number of B16.F10 cells injected. 
  
The aim of this project is to develop a sensitive and exact method for detection of the B16 
melanoma cells, e.g. in lungs or tumor draining lymph nodes, using quantitative PCR. Therefore, 
primers and probes recognizing the melanoma specific tyrosinase-related protein 2 (TRP-2), GP100 
(Pmel), and the housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA, 
were designed. The probes are attached to different dyes, allowing for detection of all the genes in 
one sample. To further optimize handling of the detection method, we use One-step Q-PCR, in 
which the cDNA synthesis step is included in the Q-PCR reaction, and therefore, each sample only 
has to be handled once after RNA extraction. 
This method is a new, very sensitive and easy-to-handle way of measuring metastasis in various 
tissues after challenge with B16 cells, and hopefully, this will optimize testing of new anti-cancer 
drugs and vaccine candidates. 
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Background 
Haematopoietic stem cell transplantation (HSCT) is a treatment used for high-risk leukaemia. The 
biological effect is based on a T- cell mediated attack on leukaemia cells (“graft-versus-leukaemia 
effect (GvL)). However, the beneficial effect is limited by significant morbidity and mortality 
caused by the graft-versus-host disease (GvHD).  
 
In GvHD, and presumably GvL, donor T-cells are activated by host-antigens presented by dendritic 
cells, a process antagonised by FoxP3 positive regulatory T-cells. However, it is at present 
unknown to what degree effective antigen presentation of allo-antigens is dependent upon residual 
dendritic cells of recipient origin – a subset of cells that is thought to decrease with time after 
HSCT.  
 
The aim of our study is to characterize the level of donor- and recipient derived dendritic cells and 
FoxP3 regulatory T-cells in tissue biopsies from SCT-patients with and without GvHD. 
 
Increased knowledge of dendritic cell chimerism in relation to development of GVHD and GvL can 
potentially open doors to more specific GVHD-treatment, and be a valuable tool in assessment of 
cellular therapy as a treatment option in patients with relapse of leukaemia after HSCT.   
 
Methods 
Biopsies from skin, gut, liver and lungs from female SCT- patients with male donors will be 
studied. The number of dendritic cells will be assessed by staining for CD1a, CD11c and S-100, and 
the fraction of donor derived cells will be assayed by hybridizing these specimens with Y 
chromosome probes. Reactions will be detected by fluorochrom- (FISH) or chromogen- (CISH) 
based detection systems. 
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Background: Rho GTPases are small GTPases that regulate cytoskeleton organization, proliferation, 
survival and cell polarization. They are present in an active GTP-bound form and an inactive GDP-
bound form. Only in the GTP-bound conformation they can interact with a wide range of effector 
molecules including serine-threonine kinases, lipid kinases and cytoskeleton proteins. The Rho 
GTPase Cdc42 is believed to be of major importance for the polarity of T cells and for the 
development of the immunological synapse between T cells and antigen-presenting cells. If correct 
Cdc42 would be of outmost importance in the development of T cells as well as in the signalling 
through mature TCR complexes. However, due to the essential role of Cdc42 in gastrulation, total 
knockout mice are non-viable, which has limited direct studies of Cdc42 function in the 
hematopoietic system. Using mice with conditional targeted disruptions of the Cdc42 gene in T 
cells, we demonstrate that Cdc42 function in different events during T cell development. 
 
Methods: In this study a T cell specific deletion of Cdc42 was applied using a Cre-loxP-mediated 
inducible system. Mice carrying the Cdc42 gene flanked by loxP sites were crossed with mice 
expressing the Cre recombinase under control of the lck promoter. Sufficient knockout efficiency in 
T cells was verified by qPCR. Cells from thymus, spleen and lymph nodes were analysed by flow 
cytometry. 
 
Results: Loss of Cdc42 resulted in reduced numbers of both CD4 and CD8 single positive cells in 
the thymus. A considerable decrease of CD3, TCRβ, CD69 and CD5 expression was observed in 
the CD8 T cells in the thymus, while only a small reduction in expression of these maturation and 
activation markers was seen in the CD4 T cells. This suggested that loss of Cdc42 lowered TCR 
signals in CD8 T cells. Consistent with the hypothesis of altered TCR signalling in CD8 thymocytes 
a higher percentage of cells with surface characteristics of activated effector and memory T cells 
was observed in CD8 cells present in spleen and lymph nodes. 
 
Conclusion: Together these findings strongly suggested a role for Cdc42 in the TCR signalling of 
CD8 T cells, and to a lesser extent CD4 T cells. 
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Certain lactobacilli species have been shown to trigger a strong induction of the pro-inflammatory 
cytokine IL-12 upon stimulation of dendritic cells (DC). We hypothesized that the strong IL-12 
inducing capacity of L. acidophilus NCFM in murine bone marrow derived DC is, at least partly, 
caused by an up-regulation of IFN-β, a key inducer of a strong adaptive immune response against 
virus, which subsequently would stimulate the induction of IL-12 and the dsRNA binding toll like 
receptor (TLR)-3. Gene expression analysis in DC revealed that L. acidophilus NCFM induced a 
much stronger expression of the genes encoding IFN-β, IL-12 and IL-10 compared to the synthetic 
dsRNA ligand Poly I:C, whereas the levels of expressed tlr-3 were similar. By the use of whole 
genome microarray gene expression, we investigated whether other genes related to the viral 
defence were up-regulated in DC upon stimulation with L. acidophilus NCFM. We found that 
multiple virus defence related genes, both early and late, were among the strongest up-regulated 
genes. The IFN-βstimulating capability was also detected in another L. acidophilus strain, but was 
not a property of other probiotic bacteria tested (B. bifidum and E. coli nissle). The IFN-βinducing 
capacity was markedly reduced in TLR-2 -/- DCs, dependent on endocytosis, and the major cause of 
the induction of tlr-3, but not Il-12, in L. acidophilus NCFM stimulated cells. Collectively, our 
results reveal that certain lactobacilli trigger the expression of viral defence genes in DC in a TLR-2 
manner through induction of IFN-β. 
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protease specificities 
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Copenhagen; 3Faculty of Health Sciences, University of Copenhagen, Denmark  
 
Peptide arrays allow implementing high-throughput screening assays for several biological 
processes involving peptide-protein or protein-protein interactions, such as enzyme/substrate, 
kinase/phosphosite, protease/polypeptide and antibody/antigen interactions. We have tested and 
analyzed the data produced by a novel peptide array technology in three selected contexts: binding 
of antibodies raised against the FLAG tag, and proteolytic cleavage of the model proteases trypsin 
and chymotrypsin. 
Bioinformatics techniques were employed to recognize the sequence motifs regulating the processes 
under study. These included a neural network-based data driven method, which can identify motifs 
in quantitative peptide binding data and use the learned patterns to predict the binding affinity of 
new peptides; a different approach aimed at finding n-mers within peptide sequences that appeared 
to consistently yield high signal intensities on the array. 
The binding preferences of the FLAG antibody reflected the strong affinity for the Tyr-Lys 
contained in the FLAG tag, and also showed weaker binding to other epitopes. In the same way, the 
main rules for trypsin and chymotrypsin cleavage specificities were confirmed, but also a few yet 
unobserved patterns emerged from the analysis. 
#44 Edita Bartaseviciute 
 
In silico prediction of T cell receptor specificity 
 
Edita Bartaseviciute, Ole Lund, Morten Nielsen 
Center for Biological Sequence Analysis (CBS), Department of Systems Biology, Technical 
University of Denmark, Kongens Lyngby, Denmark 
 
 
A key role in the cellular immunity is dedicated to T cells, which by using their unique T cell 
receptors (TCRs) recognise epitopes bound to major histocompatibility complex (MHC) molecules. 
The immune response is triggered by TCR binding to the peptide/MHC complex and depends on 
strength and duration of this interaction. Understanding of molecular basis of TCR/peptide/MHC 
interactions is very important for immune therapy and vaccine design. It is a highly labour and cost 
intensive procedure to perform direct experimental screening of TCR/peptide/MHC interactions and 
the development of computational methods capable of guiding this procedure is hence essential. In 
silico analysis of T cell receptor binding properties was made and contributed in development of 
prediction method for T cell epitopes. The method is based on predicting binding energy between 
TCRs and peptides, using contact information obtained from known 3D structures of 
TCR/peptide/MHC complexes, and predicting peptide binding aﬃnity to MHC molecules using 
advanced bioinformatics methods. Benchmarking revealed that the method performs significantly 
better than random predictions and is capable of ranking native peptides in the top 1.13% of other 
natural peptides. Having a list of peptides and a TCR protein sequence, the presented approach can 
be used to select TCR binders as poteintial epitopes worth checking experimentally. 
 
#45 Stina Rikke Jensen 
 
Quantification of specific E. coli bacteria adhering to gut epithelium in Crohn’s 
disease 
 
Stina Rikke Jensen1,5, Lisbeth Nielsen Fink1, Carsten Struve2, Claus Sternberg3, Jens Bo Andersen4, 
Jørn Brynskov5, Ole Haagen Nielsen5, Susanne Brix1  
Center for Biological Sequence Analysis, Department of Systems Biology, Technical University of 
Denmark1;  Department of Microbiological Surveillance and Research, Statens Serum Institut, 
Copenhagen2;  Center for Systems Microbiology, Technical University of Denmark3;  National 
Food Institute, Technical  University of Denmark4; Department of Gastroenterology, Medical 
Section, Herlev Hospital, University of Copenhagen5 
 
 
Adherent-invasive Escherichia coli (AIEC) comprise a new group of E. coli species named from 
their distinctive ability to adhere to and invade the intestinal epithelium. The AIEC strains have 
been associated with the ileal mucosa in Crohn’s disease (CD), and the impact of AIEC in the 
pathogenesis of CD has been further strengthened from the evidence that the ileum in CD harbors 
an abnormally high number of E. coli species.  
 
The aim of this study was to implement a quantitative method based on qRT-PCR to determine the 
number of intestinal tissue-adhering LF82, the prototype strain of AIEC, in a sample matrix of 
prokaryotic and eukaryotic DNA.  
 
Ileal tissue from two CD patients was used to study the effect of eukaryotic DNA on assay stability. 
Standard curves were prepared from tissue cut into 2 mg, 4 mg and 8 mg pieces and known 
quantities of LF82 ranging from 102 to 107 CFU. Two different TaqMan primer-probe sets were 
designed (GFP and pMT1), and evaluated for their specificity to GFP-transformed LF82. A third 
primer set was evaluated for targeting total E. coli.  
 
The GFP and pMT1 primer-probe sets showed equal specificity for LF82, resulting in a detection 
range from 103/104 to 107 CFU, and the ability to discern between 2-fold differences in bacterial 
counts. The coefficients of variations (%CV) between and within runs were below 2%. Interference 
from eukaryotic tissue DNA on assay performance was negligible. Weighing of biopsies was found 
appropriate to adjust for variations in tissue sizes as compared to 18S rDNA quantification or 
nucleic acid content.  
 
In conclusion, a high assay robustness and specificity for detection of LF82 with low variations was 
demonstrated. Thus, quantification of LF82 in intestinal biopsies is feasible using a standard curve 
generated from known quantities of LF82, and adjustment for differences in tissue sizes by weight 
measurement. This method may be of importance for future studies aiming to quantify specific 
microbes in a complex matrix of eukaryotic DNA.  
 
 
#46 Leon Jessen 
 
Identifying immunogenic motifs in the DBL5ε domain of the pregnancy 
associated malaria protein VAR2CSA by in silico pheno-genotype correlation 
 
Leon Jessen1, Sédami Gnidehou2, Philipe Deleron2, Nicaise Tuikue Ndam2, Lars Hviid3, Ali 
Salanti3, Ole Lund1 
1 Center for Biological Sequence Analysis, Department of Systems Biology, Technical University of 
Denmark, Kgs. Lyngby, Denmark; 2 Institute of Development Research, Paris Descartes University 
(Paris V). Paris, France; 3 Centre for Medical Parasitology, University of Copenhagen, 
Copenhagen, Denmark 
 
 
Each year 10,000 women and 200,000 infants die from pregnancy-associated malaria (PAM). PAM 
immunity is antibody mediated and gradually obtained with multiple pregnancies. The PAM 
associated protein VAR2CSA is surface expressed on infected erythrocytes (IE) and mediates 
infection by placental adhesion. VAR2CSA thus plays a key-role in PAM pathogenesis and has 
been shown to induce protective antibodies. VAR2CSA is therefore considered a potential 
candidate for vaccine development and it is thus imperative to identify immunogenic regions. The 
overall aim of this study is to supply further knowledge, by single domain immunogenicity analysis. 
Thereby aiding the development of a broadly protecting vaccine. 
 
The data consisted of 70 DBL5ε-subdomain sequences from placental isolates from 39 Plasmodium 
falciparum infected pregnant Senegalese women. Each sequence was associated with an array of 
experimentally determined numerical parameters. The approach was to analyse sequence variation 
by correlating the genotype of each analysed sequence, with the phenotype, i.e. the associated 
numerical parameters. This was done by applying statistical evaluations of the distribution of each 
residue at each position in a protein multiple alignment of sequences ranked by each numerical 
parameter. 
 
Using this approach, primi-/multigravidae motifs were indeed identified (TFKNI/deletion 
respectively). As the motif is parity dependent and immunity is gradually acquired with parity, the 
motif could be directly or indirectly involved in immunogenicity. Further experimental evaluation is 
proposed. 
 
The overall aim of my PhD programme is to develop and apply in silico methods and tools for 
analysing and predicting the correlation between pheno- and genotype and its involvement in 
immunogenicity. 
#47 Marie Kragh 
 
Exploring the bacterial airway colonization in Danish infants of mothers with 
atopy 
 
Marie Kragh1, Susanne Brix1, Klaus Bønnelykke2, Hans Bisgaard2 
1Molecular Immune Regulation Group, Department of Systems Biology, Technical University of 
Denmark, Kgs. Lyngby, Denmark; 2 Copenhagen Prospective Studies on Asthma in Childhood, 
Danish Pediatric Asthma Center, University of Copenhagen, Gentofte, Denmark 
 
Asthma and wheezy disorders are very common chronic diseases in children in the Western world. 
The diseases are heterogeneous with little to differentiate their clinical presentation, causing 
inadequate management and prevention. Still, our understanding of specific asthma endophenotypes 
is limited. In order to improve prevention, diagnosis and treatment, an increased understanding of 
both environmental and genetic etiologies, their interaction, and the host mechanisms involved is 
needed. 
 
Our collaborators on this PhD study found in their cohort study of 411 children of asthmatic 
mothers (the Copenhagen Prospective Study on Asthma in Childhood (COPSAC2000)), that the 
presence of certain bacteria in the upper respiratory tract may increase the risk of asthma 
development. Consequently, we propose that colonization of the upper airway with certain 
pathogenic bacteria early in life may result in a bacteria-induced asthma endophenotype. Still, 
however, little is known about the diversity of bacteria in the upper airway of young children, and 
how certain bacteria may prime to the deregulated lung immune response leading to asthma 
development.  
 
The aim of this PhD study is to investigate the nasopharyngeal microbiota from neonates enrolled in 
COPSAC2000. This is accomplished by analyzing bacterial DNA fingerprints using explorative data 
analysis. The obtained results are correlated with available clinical, environmental, genetic and 
immunological data from the children in order to reveal specific factors that influence the diversity 
and composition of the bacterial community of airways and promote or protect against development 
of atopic diseases in early childhood.   
 
 
 
 
 
 
 
 
 
 
#48 Jeppe Madura Larsen 
 
Asthma pathogenesis: Do bacteria play a role? 
 
Jeppe Madura Larsen, Hanieh Sadat Musavian, Tariq Mahmood Butt, Susanne Brix 
Molecular Immune Regulation, Center for Biological Sequence Analysis, Department of Systems 
Biology, Technical University of Denmark 
 
 
Asthma is a highly complex disease that may arise from different etiology. Recent studies have 
indicated that bacteria may play a role in the pathogenesis of at least one particular asthma 
endotype. Colonization with certain pathogenic bacteria in pre-symptomatic airways of children has 
been associated with later asthma development. Furthermore, the airways of asthma patients have 
been found to be associated with a particular bacteria colonization pattern compared to lungs of 
healthy individuals. Contrarily, healthy lungs were found to be associated with the colonization of 
non-pathogenic commensal bacteria found less frequently in asthmatics. These findings suggest a 
divergent role of different bacteria in the development of asthma. Our studies address the 
physiological role of asthma-associated and lung commensal bacteria in pulmonary immune 
responses. 
#49 Bent Petersen 
 
NetTurnP – neural network prediction of beta-turns by use of evolutionary 
information and predicted protein sequence features 
 
Bent Petersen1, Claus Lundegaard1, Thomas Nordahl Petersen1,* 
1Center for Biological Sequence Analysis CBS, Department of Systems Biology, Technical 
University of Denmark, Lyngby, Denmark 
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β-turns are the most common type of non-repetitive structures, and constitute on average 25% of the amino 
acids in a protein. The formation of β-turns plays an important role in protein folding, protein stability and 
molecular recognition processes. 
 
β-turns are often accessible and generally hydrophilic, two characteristics of antigenic regions. For this 
reason they are suitable candidates for being involved in molecular recognition processes. Pellequer et. al. 
found that 50% of the linear B-cell epitopes in a small dataset of 11 proteins were located in turn regions. 
Thus prediction of β-turns could improve the prediction of epitopes. Krchnak et al. found that the parts of a 
protein, which can induce protein-reactive anti-peptide anti-bodies, mostly reside in regions that have a high 
tendency to form β-turns. A more recent article by the same authors showed that peptide sequences including 
a β-turn conformation tended to induce antibodies that were able to cross-react with the parent protein. β-turn 
and coil conformations have also previously been used to predict linear epitopes. Furthermore, β-turn types I 
and II, are important for binding between phospho-peptides and SH2-domains. 
 
In the present work, neural network methods have been trained to predict β-turn or not and individual β-turn 
types from the primary amino acid sequence, by use of evolutionary information and predicted protein 
sequence features. The individual β-turn types I, I’, II, II’, VIII, VIa1, VIa2, VIba and IV have been 
predicted based on classifications by PROMOTIF, and the two-class prediction of β-turn or not is a superset 
comprised of all β-turn types. The performance is evaluated using a golden set of non-homologous sequences 
known as BT426. Our two-class prediction method achieves a performance of: MCC = 0.50, Qtotal = 82.1%, 
sensitivity = 75.6%, PPV = 68.8% and AUC = 0.864. We have compared our performance to eleven other 
prediction methods, that obtain Matthews correlation coefficients in the range of 0.17 – 0.47. For the type 
specific β-turn predictions, only type I and II can be predicted with reasonable Matthews correlation 
coefficients, where we obtain performance values of 0.36 and 0.31, respectively. NetTurnP achieves the 
highest reported Matthews correlation coefficient of 0.50, and furthermore shows improved performance on 
some of the specific β-turn types.  
 
Conclusion:  A method for the general and specific prediction of β-turns has been developed and 
implemented as a webserver, which is freely available at http://www.cbs.dtu.dk/services/NetTurnP/. 
NetTurnP is the only available webserver that allows submission of multiple sequences. It combines 
predictions from relative surface accessibility, secondary structure, β-turn/non-β-turn and position-specific β-
turns into an ensemble of the best performing neural networks. The presented method shows the highest 
reported correlation coefficient of 0.50 for the general prediction of β-turns. For the type specific β-turn 
predictions, we show some improvement compared to other methods, but in general these are still of poor 
quality even for the best machine learning methods. We obtain the highest correlation coefficient of 0.36 for 
type I β-turn predictions.  
 
 
#50 Kerstin Skovgaard 
 
Expression of coding (mRNA) and non-coding (microRNA) RNA in lung tissue 
and blood isolated from pigs suffering from bacterial pleuropneumonia  
  
Skovgaard  K, Schou KK, Wendt KT, Heegaard PMH  
National Veterinary Institute, Technical University of Denmark. kesk@vet.dtu.dk 
  
 
MicroRNAs are small non-coding RNA molecules (18-23 nt), that regulate the activity of other 
genes at the post-transcriptional level. Recently it has become evident that microRNA plays an 
important role in modulating and fine tuning innate and adaptive immune responses. Still, little is 
known about the impact of microRNAs in the development and pathogenesis of lung infections. 
  
Expression of microRNA known to be induced by bacterial (i.e., LPS) ligands and thus supposed to 
play a role in the regulation of antimicrobial defence, were studied in lung tissue and in blood from 
pigs experimentally infected with Actinobacillus pleuropneumoniae (AP). Expression differences of 
mRNA and microRNA were quantified at different time points (6h, 12h, 24h, 48h PI) using reverse 
transcription quantitative real-time PCR (Rotor-Gene and Fluidigm). Expression profiles of miRNA 
in blood of seven animals were further studied using miRCURY™ LNA arrays (Exiqon, Denmark). 
   
All AP infected animals had significantly higher levels of mRNA coding for inflammatory 
mediators as IL-6 and IL-8 as well as the acute phase protein SAA, in the lung compared to the 
control group.  
  
MiR-223 was found to be highly up regulated, followed by miR-146a and to a lesser degree miR-
155 in lung tissue of the AP infected animals. MiR-233 was also found to be up regulated in blood 
based on both microarray and real-time PCR. Mir-233 has been found to be a negative regulator of 
neutrophil proliferation and activation, and might act to limit the potentially harmful consequences 
of the accumulation of infiltrating neutrophils in AP infected lungs.  
#51 Thomas Stranzl 
NetCTLpan: pan-specific MHC class I pathway epitope predictions 
 
Thomas Stranzl1, Mette Voldby Larsen1, Claus Lundegaard1, Morten Nielsen1 
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Reliable predictions of immunogenic peptides are essential in rational vaccine design and can 
minimize the experimental effort needed to identify epitopes. In this work, we describe a pan-
specific major histocompatibility complex (MHC) class I epitope predictor, NetCTLpan. The 
method integrates predictions of proteasomal cleavage, transporter associated with antigen 
processing (TAP) transport efficiency, and MHC class I binding affinity into a MHC class I 
pathway likelihood score and is an improved and extended version of NetCTL. The NetCTLpan 
method performs predictions for all MHC class I molecules with known protein sequence and 
allows predictions for 8-, 9-, 10-, and 11-mer peptides. In order to meet the need for a low false 
positive rate, the method is optimized to achieve high specificity. The method was trained and 
validated on large datasets of experimentally identified MHC class I ligands and cytotoxic T 
lymphocyte (CTL) epitopes. It has been reported that MHC molecules are differentially dependent 
on TAP transport and proteasomal cleavage. Here, we did not find any consistent signs of such 
MHC dependencies, and the NetCTLpan method is implemented with fixed weights for proteasomal 
cleavage and TAP transport for all MHC molecules. The predictive performance of the NetCTLpan 
method was shown to outperform other state-of-the-art CTL epitope prediction methods. Our results 
further confirm the importance of using full-type human leukocyte antigen restriction information 
when identifying MHC class I epitopes. Using the NetCTLpan method, the experimental effort to 
identify 90% of new epitopes can be reduced by 15% and 40%, respectively, when compared to the 
NetMHCpan and NetCTL methods. The method and benchmark datasets are available at 
http://www.cbs.dtu.dk/services/NetCTLpan/. 
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HIV-induced TLR-CLR crosstalk in human plasmacytoid dendritic cells 
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Plasmacytoid dendritic cells (pDCs) have been associated with both beneficial and detrimental 
effects during an HIV-infection. Little is presently known about the intracellular pathways in pDCs 
that mediate these processes, but evidence suggest that C-type lectin receptor (CLR) crosstalk with 
Toll-like receptors (TLR) may play an important role. The present objective was to study the CLR-
TLR crosstalk that is induced in human pDCs upon challenge with HIV-derived TLR and CLR 
ligands. We tested three different recombinant HIV-1 gp120s: IIIB (CHO-derived), 96ZM651 (Sf9-
derived) and BaL (HEK-293-derived) which mediated diverse modulation of TLR7-induced IFN-
alpha-2a and CD86 expression in pDCs. These differences may possibly be explained by different 
posttranslational glycosylations in the different gp120-expression systems. The three gp120s all 
lead to inhibition of TLR7-mediated CD40-upregulation and increased CCR7-upregulation. The 
modulating effects of gp120 were concentration-dependent and no significant modulations were 
obtained below concentrations of 100 µg/mL. Finally we have found that TLR7-activated pDCs 
express the mannose receptor (CD206), which may play an important role in the observed CLR-
TLR crosstalk.  
#53 Rikke Brandt Sørensen 
 
Viable S. typhimurium distinctly modulate the phenotype of human dendritic 
cells as compared to LPS and non-replicating bacteria 
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Salmonella typhimurium (ST) is a facultative intracellular anaerobe which upon colonization of the 
intestine is able to penetrate the intestinal epithelia and replicate both in phagocytes and non-
professional antigen-presenting cells. Dendritic cells (DCs) play an important role in innate 
immunity against Salmonella, but are also believed to play an important role in Salmonella invasion 
and dissemination by acting as vehicles for the bacteria. As the bacteria-induced DC phenotype is of 
great importance for the ensuing T cell response, we studied the effect of viable S. typhimurium 
(ST) on various phenotypic markers in human monocyte-derived dendritic cells (moDC), and 
compared to the response induced by UV-inactivated, and heat-inactivated ST, as well as ST LPS. 
We found that the phenotype induced by viable bacteria differed significantly from that induced by 
inactivated bacteria, the latter resembling a LPS-induced response pattern. Compared to moDCs 
stimulated with ST LPS and inactivated ST, viable ST down-regulated the expression of CD40 and 
the mannose receptor, but did not alter the display of DC-SIGN, HLA-DR, CD86, TLR2 or TLR5. 
Even though secretion of both IL-10 and IL-12p70 was induced by viable ST, the IL-10/IL-12p70 
ratio was highly skewed towards IL-10 production (IL-10/IL-12p70-ratio = 70), suggesting that the 
microenvironment favor pathogenic dissemination and not pathogenic clearance. Furthermore, 
when studying the effect of different bacteria-to-DC ratios (multiplicity of infection; MOI), we 
found that the ST-induced modulation in moDCs was dynamic and varying with MOI.  
Conclusively, the present results emphasize that viable Salmonella induces a distinct phenotypic 
change in moDCs that depend on the number of infecting bacteria, and diverges from that induced 
by non-replicating Salmonella bacteria.  
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Possible effect of age at immunization and quality of immune response following 
MAP subunit vaccination in calves  
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Mycobacterium avium subsp. paratuberculosis (MAP), the agent of Johne’s disease, causes 
systemic infection and chronic intestinal inflammation in many animal species. Neonates are more 
susceptible to the infection due to high degree of exposure from their dams and possibly less 
developed immune system. The only vaccines available against MAP have been limited to 
veterinary use and comprised attenuated or killed organisms. However, none of these vaccines are 
able to completely prevent infection or shedding of bacteria. Considering the fact that MAP 
infection occurs at a young age and the animal remains in the subclinical phase for 2-3 years, an 
effective vaccine should not only elicit strong immune response in young animals, but also a quality 
of the T-cell response that correlates with long term protection. Here we report the possible effect of 
age at immunization and quality of immune response following immunization of calves with 
recombinant MAP proteins formulated with DDA/TDB (CAF01) adjuvant. Vaccine comprised of 
one heat shock protein, two ESAT-6 family members and two secreted mycobacterial components 
fused with CAF01 adjuvant. A total of 27 male jersey calves were divided into 3 groups of 9 calves 
each with first vaccination at 2, 8 and 16 weeks of age, respectively. Vaccine induced immune 
response, mainly the Th1 type cytokine secretion, was evaluated in different age groups following 
booster doses at equal time intervals. Preliminary results show higher antigen specific IFN-γ levels 
in response to heat shock protein and ESAT-6 family member protein antigens. However, it was 
observed that there was no effect of age on the IFN-γ producing capacity of the animals in the 
different age groups after stimulation of whole blood with SEB. As the vaccine trial has recently 
completed results will be compiled and presented. Findings from this work could be interesting to 
determine the appropriate age of vaccination so as to generate the memory T cell pool and for MAP 
vaccine challenge experiments. 
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Immunological mediators of disease initiation and progression in novel 
childhood asthma endotypes: Mechanistic basis for early preventive strategies 
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Brix1 
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Asthma, wheezy disorders, and other atopic diseases are the most common chronic diseases among 
children and represent a heterogeneous group with little to differentiate clinical presentation into 
defined disease endotypes. Atopic disorders arise from an aberrant immune system likely triggered 
by the complex interaction between individual genetic alterations and environmental factors 
encountered during pregnancy and early life. Thus, in depth understanding of the involved genetic, 
environmental, and immunological mechanisms is needed in order to improve prevention, 
diagnosis, and treatment.  
 
The Copenhagen Prospective Studies on Asthma in Childhood (COPSAC2010) birth cohort is 
founded on an extensive clinical monitoring of children with focus on atopic diseases, 
environmental exposures and collection of samples for biological analysis. The purpose of the 
cohort is to investigate interactions between mother’s diet during pregnancy, child genetics, and 
bacterial colonization of the airways relating to development of atopic diseases.       
In the present PhD project, we aim to characterize immunological and lung mucosa-associated 
mechanisms within the cohort to elucidate environmental and genetic factors that shape aberrant 
immune responses in atopy. Innate immune responses in 18th month old children from the 
COPSAC2010 cohort study will be evaluated and correlated to the diet of the pregnant mother, the 
genetic profile of the child, and bacterial airway colonization in early life.  
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Alkali insoluble cell wall fragments of Aspergillus fumigatus which induced 
allergic response in lungs of C57BL/6 mice is recognized by chitin binding type 
II receptor FIBCD1 
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Purpose:  Aspergillus fumigatus is a common opportunistic pathogen responsible for allergy and 
infection. The cell wall of fungus is a physically rigid layer, which protects fungal cells from 
environment. The major cell wall polysaccharide of Aspergillus fumigatus contains chitin 
covalently linked to β-1-3 glucan and galactomannan, which can initiate an innate immune 
response. The well-defined link of initial molecular recognition and immune response towards 
fungal chitin polysaccharides remain however unclear. Fungal cell wall polymers are classically 
divided in 2 groups depending on their solubility in alkali. The alkali insoluble fraction of 
Aspergillus fumigatus mainly contains the glucan-chitin complex.  
 
Aim:  To investigate the mucosal epithelial type II receptor FIBCD1 binding to chitin present on 
Aspergillus fumigatus and identify the possible role of FIBCD1 in modulation of the allergic 
immune response induced by fungal polysaccharides in vivo and in vitro.  
 
Materials, Methods and Results: Using fluorescence microscopy we investigated the interaction 
of FIBCD1 to Aspergillus fumigatus (afu) and found that rFIBCD1 co-localized with chitin in the 
live organism. Later on the instillation of alkali insoluble fractions (AIF) mainly containing β-
glucan and chitin was evaluated. Instillation of the AIF in mice lungs resulted in significantly 
increased granulocyte counts and total cell counts, increased chitinase activity and increased 
eosinophil peroxidase level in lung lavage when compared to mice receiving PBS. These results 
indicate a polysaccharide-induced recruitment of cells and production of chitinase, which may leads 
to Th2 immune response. We also stimulated Monocytes differentiating towards macrophages for 
16 hr with AIF, and afu fragments and found that stimulation leads to increased expression of IL1-
β, TNF-α and IL-8 measured by realtime-PCR. 
 
Future perspective: Epithelial cells in the airways or the gut are often exposed to fungal 
polysaccharides by inhalation or ingestion and respond by increasing the expression of chitinase 
and chitin binding proteins. An immune response to chitin can develop in to Th1 or Th2 response 
depending upon the presence of other microbial components. FIBCD1 is a type 2 trans membrane 
protein preferentially present on epithelial lining which binds to Aspergillus chitin. The exact 
mechanism for recognition of chitin however remains unclear. We will now analyze the role of 
FIBCD1 in modulation of allergic immune responses induced by chitin, Alkali insoluble extract and 
by afu in-vivo by establishing an allergic model in wild type and FIBCD1 deficient mice. The 
identification of mechanisms involved in chitin induced modulation of innate and adaptive immune 
responses may provide novel insight into prevention of allergic airway inflammation.  
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FIBCD1: A novel mammalian pattern recognition receptor for chitin 
 
Mark A. Hammond1, Anders Schlosser1, Theresa Thomsen1, Grith Lykke Sørensen1, Uffe 
Holmskov1 
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Background:  Fibrinogen C domain-containing protein 1 (FIBCD1) is a type II transmembrane 
protein located on the luminal side of intestinal epithelial cells. FIBCD1 binds specifically to 
acetylated compounds, such as chitin, through the C-terminal fibrinogen-related domain (FReD). 
Chitin is a highly acetylated homopolymeric β-1,4-N-acetylglucosamine carbohydrate found in 
organisms fungi and parasitic nematodes. We have shown that FIBCD1 binds chitin and internalises 
the model ligand acetylated BSA and directs it for endosomal degradation. 
 
Aim: In this project we aim to characterise the functional aspects of the binding between FIBCD1 
and chitin. We have constructed FIBCD1-expressing epithelial cell lines in which we seek to 
identify the intracellular signalling upon binding to chitin or model ligand. Initially this will be 
investigated by microarray-based methods and subsequent verification by quantitative real-time 
PCR. The mechanisms of internalisation of acetylated structures mediated by FIBCD1 will be 
investigated by performing a range of strategic point mutations in the cytoplasmic tail of FIBCD1. 
 
Results: The colon epithelial cell line HCT-116 has been stably transfected with full length 
FIBCD1 in order to use for stimulatory studies and the cell line HEK293 has been stably transfected 
with FIBCD1 containing point mutations in the cytoplasmic tail in use for internalisation studies. 
 
Conclusion: We have identified FIBCD1 as the first membrane bound FReD molecule in mammals 
and the first pattern recognition receptor that binds chitin and directs acetylated structures for 
degradation in the endosome. The localisation of FIBCD1 on the luminal surface of the intestinal 
epithelia points to a role in innate immunity and/or gut homeostasis. 
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The molecular interaction between M- and L-ficolin and chitin  
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Thiel2, Uffe Holmskov1 
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L-ficolin is a serum protein, while M-ficolin is mainly located in secretory granules and on the 
surface of monocytes and neutrophils. M- and L-ficolin both recognize acetylated structures, 
including N-acetylglucosamine (GlcNAc), through different sites in the fibrinogen-related domain 
(FReD), and functions as PRMs capable of initiating the lectin pathway.  
Chitin is a linear homopolymer of GlcNAc residues, which next to cellulose is the most abundant 
known biopolymer. Vertebrates are exposed to chitin both through food ingestion and when 
infected with parasites and fungi. Chitin has recently been identified as a PAMP that modulates the 
allergic response in mice, and the purpose of the present study was to investigate the hypothesis that 
chitin would serve as a ligand for ficolins. 
Recombinant M- and L-ficolin were produced and their binding properties were investigated 
through binding experiments using acetylated BSA, acetylated beads, chitin from crab shells and 
chitin beads. 
Our initial observations have demonstrated that M-ficolin bound to acetylated BSA and acetylated 
beads in a calcium-dependent manner and the binding could be abolished by the addition of acetate, 
indicating that the binding is mediated through the calcium-dependent acetyl-binding S1 site. L-
ficolin was likewise found to interact with acetylated BSA and acetylated beads, but in a calcium-
independent manner, however only the binding to the acetylated beads could be inhibited by the 
addition of acetate. Both M- and L-ficolin bound chitin, but only the binding of M-ficolin to chitin 
was calcium-dependent. This suggests that M-ficolin binds to chitin through the S1 site, while the 
L-ficolin binds chitin in the S2 or S3 site.  
These findings indicate that M- and L-ficolin have the potential to modulate the immune defence 
against inhaled fungi through chitin interaction.  
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Introduction: T cell mediated autoimmune responses are implicated in the pathogenesis of multiple 
sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). EAE can be 
induced by CNS antigen specific CD4+ T cells producing IFN-γ (Th1 subtype), IL-17 (Th17 
subtype), or CD8+ T cells. In contrast to CD8+ dominated MS, most EAE models are CD4+ 
dominated.  
 
T cell migration is regulated by chemokines. Th17 cells express CCR6, a receptor for CCL20 and 
Th1 cells express CXCR3, a receptor for CXCL9, CXCL10 and CXCL11. CD8+T cells infiltrating 
the CNS in response to viral infection express CXCR3. Like CD4+ T cells, CD8+ T cells can 
differentiate into IFN-γ producing and IL-17 producing types. In EAE, CD8+ T cells are a good 
source of IFN-γ but poor source of IL-17. Very little is known about chemokine receptor expression 
by CD8+ T cells in EAE. 
 
Aim: To study localization and chemokine receptor expression profile of CD8+ and CD4+ T cells 
infiltrating the CNS. 
 
Study description: Flow cytometry was used to determine CXCR3 and CCR6 expression on CD8+ 
and CD4+ T cells infiltrating brain and spinal cord. EAE was induced by immunizing mice with 
recombinant myelin oligodendrocyte glycoprotein (MOG, residues 1-125) or with peptide p35-55. 
 
Results and discussion: CD4+T cells constituted the majority in both EAE models. CCR6 was 
expressed by a small fraction of CD4+T cells. The majority of infiltrating CD8+ T cells expressed 
CXCR3. However, CD8+ T cells expressing CCR6 were rarely detected. This concurs with the 
observation that CD8+ T cells do not produce IL17 during EAE. Both models are biased towards 
immune response dominated by CD4+ T cells. Future studies will focus on autoimmune response 
dominated by CD8+ T cells. 
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Microfibril-associated protein 4 (MFAP4) was recently identified as a candidate marker of hepatic 
cirrhosis by the use of a proteomic approach followed by measurements of serum variation. 
Knowledge on normal variation and heritability of serum MFAP4 however remains to be 
determined in order to apply the utilization of systemic variation or possibly genetic variation in 
MFAP4 in fibrotic disease. 
 
We have developed an MFAP4 ELISA assay and here we investigate the serum variation in a 
population of Danish adult twins (GEMINAKAR). Serum sMFAP4 was measured in 1422 self-
reported healthy twins. The study population was divided in 291 pairs of monozygotic (MZ) twins, 
291 pairs of dizygotic same-sex (DZ-SS) twins and 129 pairs of dizygotic opposite-sex (DZ-OS) 
twins. Mean sMFAP4 in the study population was 19.0 IU/ml (3.41–35.5 IU/ml), which is in 
accordance with previous results. The sMFAP4 distribution was right-skewed and in order to 
approximate a bivariate normal distribution the data were transformed to the logarithmic scale. 
Without adjusting for confounding effects an intraclass correlation coefficient of 0,5597 for MZ and 
0.4680 for DZ-SS was calculated, indicating that the systemic level of sMFAP4 is influenced by 
additive genetic factors (a=0.18), shared genetic factors (c=0.38) and environmental factors 
(e=0.44). The data will be controlled for possible confounding factors, such as age, gender, and 
current smoking status, in the final heritability analysis. 
 
Further knowledge of sMFAP4 variation in normal, healthy adults will be achieved by investigation 
of the serum variation in relation to physical activity. Together these studies will provide the 
background for conducting studies on sMFAP4 variation in case control studies of relevant 
disorders characterized by tissue remodelling and fibrosis. 
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A complex called HAMLET formed from two naturally occurring constituents of human breast 
milk, oleic acid and α-lactalbumin, has been reported to kill tumor cells. Using an alternative 
preparation method and substituting the human protein for the readily available bovine α-
lactalbumin, we have prepared a new variant of the α-lactalbumin/oleic acid complex.  
The cytotoxicity of the α-lactalbumin/oleic acid complex was comparable to that of HAMLET. 
Oleic acid in the absence of α-lactalbumin was also toxic to the cell lines. However, when 
compared on the basis of the oleic acid content, the cytoxicity of the α-lactalbumin/oleic acid 
complex was 20-fold higher than of oleic acid alone. The sensitivity to treatment with oleic acid or 
the α-lactalbumin/oleic acid complex differed between the tested cell types. Depending on the cell 
type, the mode of dose-dependent cell death resembled either necrosis or apoptosis, as measured by 
flowcytometry using AnnexinV and DNA-dye 7AAD. The cytotoxic effect was attenuated by the 
presence of serum and serum albumin. 
 
Conclusion: A complex of α-lactalbumin and oleic acid induced cell death of cancer cells through 
different mechanisms depending on the cell line and concentration. The cytotoxic activity of the α-
lactalbumin/oleic acid complex was inhibited by five percent serum. 
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The pattern-recognition molecules of the lectin pathway, mannan-binding lectin (MBL) and the 
three ficolins (H-, L-, and M-ficolin), circulate in complexes with three MBL-associated serine 
proteases: MASP-1, -2, and -3. In addition, a non-enzymatic splice product of the MASP2 gene, 
MAp19, has been described. We recently presented the first report of a fifth associated protein, 
MAp44, an alternative splice product of the MASP1 gene. Three proteins are thus produced from 
the MASP1 gene: MASP-1 and MASP-3, which share five domains constituting the A-chain, but 
have unique protease domains; and MAp44, which shares the first four domains with MASP-1 and -
3, and additionally has 17 unique C-terminal residues. We have previously shown that MAp44 and 
MASP-3 may inhibit MASP-2 mediated C4 activation. Here, we present sandwich assays for 
MASP-3 and MAp44 and the results obtained using these. MASP-3 and MAp44 are found in serum 
in complexes eluting corresponding to 600-800 kDa and 500-700 kDa, respectively. The level of 
MASP-3 in donor sera (n=200) is log-normally distributed with a median value of 5.0 µg/ml (range: 
1.8-10.6 µg/ml), and the corresponding value for MAp44, likewise log-normally distributed, is 1.7 
µg/ml (range: 0.8-3.2 µg/ml). MASP-3 levels are low at birth and reach normal levels within the 
first 6 months, whereas MAp44 drops slightly during the first 6 months. Concomitant with the acute 
phase response in patients undergoing colon cancer surgery, levels of both proteins drop slightly 
within 1-2 days, but whereas MASP-3 recovers to baseline within another 2 days, MAp44 
overshoots, only to reach baseline at around day 30. 
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The elicitation of broadly neutralising antibodies (Nab) remains the primary and most challenging 
goal in HIV-1 vaccine development. Although a few anti-HIV-1 monoclonal antibodies with 
broadly neutralising capability have been isolated from infected individuals, none of the 
immunisation strategies thus far explored has proven effective in inducing similar antibodies. 
Objective of the project is the development of a variety of ‘next-generation’ HIV-1 envelope-based 
immunogens that in combination with new adjuvant formulations are capable of eliciting high-titer 
broadly Nab responses. The strategy is based on one side on the identification and cloning of 
envelopes that have successfully elicited broad Nabs in 
their natural hosts, focusing on HIV-1 strains derived from patients with high-titered broad Nabs in 
their sera; on the other side, to introduce rational modifications into these HIV-env based 
immunogens, with the aim of exposing cryptic conserved neutralization epitopes and permitting 
their efficient presentation to the immune system. HIV-1 envelopes will be expressed in viral 
vectors or as trimeric (gp150) soluble proteins and screened for their immunogenicity and 
antigenicity in rabbits. New immunogens will be evaluated in prime-boost regimens in rabbits using 
novel effective adjuvant formulations. Immunogen/adjuvant combinations that prove most effective 
in eliciting broadly Nabs both systemically and at the mucosal level will be evaluated in non-human 
primates for their immunogenicity and efficacy upon challenge with live heterologous virus. 
Finally, formulations that will elicit protective immunity in non-human primates will be forwarded 
for proof-of-principle testing in humans. 
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Although CD8+ T-cells help controlling Mycobacterium tuberculosis (Mtb) infection, their Mtb-
antigen repertoire, in vivo frequency and functionality in human tuberculosis (TB) remain largely 
undefined.  We have performed genome-based bioinformatics searches to identify new Mtb-
epitopes presented by major HLA-class I supertypes, A2, A3 and B7 (covering 80% of the human 
population).  
 
432 Mtb-peptides predicted to bind to HLA-A*0201, HLA-A*0301 and HLA-B*0702 (representing 
the above supertypes) were synthesized and HLA-binding affinities determined.  Peptide-specific 
CD8+ T-cell proliferation-assays (CFSE-dilution) in 44 Mtb responsive donors identified 70 new 
Mtb-epitopes.  Using HLA/peptide tetramers for the 18 most prominently recognized HLA-
A*0201-binding Mtb-peptides, recognition by TB-patients’ CD8+ T-cells was validated for all 18 
epitopes.  ICS for IFN-γ, IL-2 and TNF-α revealed mono-, dual- as well as triple-positive CD8+ T-
cells, indicating these Mtb peptide-specific CD8+ T-cells were functional.  Moreover, these T-cells 
were primed during natural infection, since they were absent from Mtb-noninfected individuals.  
Control CMV-peptide/HLA-A*0201 tetramers stained CD8+ T-cells in Mtb-infected and non-
infected individuals equally, whereas Ebola-peptide/HLA-A*0201 tetramers were negative. 
 
In conclusion, the Mtb-epitope/antigen repertoire for human CD8+ T-cells is much broader than 
hitherto suspected; and the newly identified Mtb-antigens are recognized by (poly)functional CD8+ 
T-cells during control of infection.  These results impact on TB-vaccine design and biomarker 
identification. 
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T follicular helper (Tfh) cells are a subset of CD4+ T cells with an enhanced ability to provide B 
cell help and support germinal center (GC) responses, processes important for the generation of 
long-lived and affinity matured antibody responses. Expression of the chemokine receptor CXCR5 
characterizes Tfh cells and enables their follicular localization, and thereby also facilitates 
interaction with cognate B cells. The transcriptional repressor Bcl-6 was recently demonstrated to 
be both sufficient and necessary to drive in vivo Tfh development, indicating that Bcl-6 acts as a 
master regulator in Tfh cell differentiation. However, the molecular cues that induce Bcl-6 
expression and promote the Tfh phenotype is not yet defined. To address this, we have activated 
naïve CD4+ T cells in vitro, either in co-cultures with dendritic cells (DC) or with agonistic 
antibodies against CD3 and CD28. From these experiments we have seen that both the DC and 
antibody activated CD4+ T cells express comparable levels of CXCR5 mRNA, but this is not 
synonymous to surface expression of the protein as only the DC activated CD4+ T cells display 
CXCR5 that can be detected by flow cytometry. Further, the in vitro activated CXCR5+CD4+ T 
cells do not express elevated mRNA levels of Bcl-6 and IL-21, markers strongly associated to the 
Tfh phenotype. Collectively, our results indicate that DCs provide signals to the T cells necessary 
for surface expression of CXCR5, but are not sufficient to complete the process of Tfh 
development. With this observation, we are also interested in evaluating the ability of different DC 
subsets to induce CXCR5 expression on CD4+ T cells. Currently, we are looking at the CD103+ and 
CD103- DCs, which previously have been shown to hold different capacities to induce gut-homing 
effector T cell subsets, to determine if they could also play a role in Tfh development.  
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Inflammatory bowel disease (IBD), comprising Crohn´s disease and ulcerative colitis, is 
characterized by chronic relapsing inflammation of the gut. Increased proteasome activity, 
associated with high expression of immunoproteasomes has been shown to enhance 
proinflammatory signalling in the inflamed mucosa of IBD patients. Especially, immunoproteasome 
subunit LMP7 was highly abundant in both groups of patients. Thus, we tested whether LMP7 is a 
suitable target for the treatment of inflammation in experimental colitis. To assess this, wild type 
(WT) and lmp7-/- mice were treated with Dextran sodium sulfate (DSS) to induce colitis. We found 
that lmp7-/- compared to WT mice develop significantly attenuated colitis as judged by reduced 
weight loss and tissue damage. Further, we show that reduced proinflammatory signalling via NF-
kB limits the secretion of proinflammatory cytokines and chemokines, consequently reducing the 
infiltration of the colon by neutrophils as well as blocking the development of inflammatory Th1 
and Th17 T cell responses. In summary, our experiments demonstrate that modulation of the 
proteasome activity by targeting LMP7 is effective in attenuating experimental colitis, and confirm 
that this immunoproteasome-subunit is a promising target for the therapy of IBD. 
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Objectives: To test the feasibility of investigating the frequency and phenotype of antigen-specific 
memory T cells post-imunization in infants using small amounts of frozen PBMC. 
 
Methods: Frozen PBMC from children at 6 and 9 months which were immunized against pertussis, 
difteria, polio and tetanus following the same vaccine schedule were stimulated with TETRAVAC 
in vitro for 20 hrs. The cytokine secretion assay (CSA) was used in combination with multicolor 
flow cytometry using the following antibodies: anti-CD3, anti-CD4, anti-CD8, anti-CD45RO, anti-
INF-γ and anti-CD27.  
 
Results: We have observed a clear increase of the efector memory, central memory and naive T 
cells in the CD4+ INFγ+ T cell compartment  at 6 and 9 months of age in the same individual, but  a 
decrease of the terminal effector T cells in the 9th month. 
CD8+ T cell response showed an increase of the central memory and naive T cells at 9 months 
compared to the 6th month, while a decrease of the effector memory and terminal effector T cells 
was observed at 9 months compared to 6 months of age. The memory compartment of the non 
responders didn't show any differences between 6 and 9 months in either CD4+ or CD8+ T cells. 
 
Perspectives: Our results must be confirmed with a larger number of samples. Improved 
understanding of the generation of functional memory T cells in children may provide new 
strategies to identify individuals at high-risk of developing autoimmune diseases and to follow 
disease progression. 
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Dendritic cells (DCs) are bone marrow-derived professional antigen presenting cells that play a key 
role in bridging the innate and adaptive immune defense. Their primary task is the uptake and 
presentation of antigen to T cells in order to initiate an adaptive immune response. Dendritic cells 
have been widely used in cancer therapy being loaded with different types of antigen in order to 
elicit an immune response against the cancer. DanDrit Biotech A/S produces a dendritic cell based 
vaccine loaded with allogeneic tumor lysate. The vaccine is produced from monocytes isolated from 
the patient’s own blood which is cultured for 8 days in vitro to generate mature dendritic cells 
which is then injected into the patient. The melanoma cell lysate providing the antigen is produced 
from a cell line rich in the expression of cancer/testis antigens. We studied the DCs during their 
normal 8 days of culture and for two additional days in order to characterize their surface marker 
expression, cytokine secretion and antigen uptake. This verified that using our culture method does 
produce DCs with a mature phenotype with surface marker expression and secretion of IL-12 and 
IL-23 comparable to those of other studies. Furthermore, antigen uptake both via receptor-mediated 
endocytosis as well as macropinocytosis takes place while DCs display an immature phenotype, but 
not after inducing maturation, which is also consistent with previous observations.  
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Background  
The two major clinically defined forms of inflammatory bowel disease (IBD), Crohn´s Disease 
(CD) and Ulcerative Colitis (UC) are chronic remittent or progressive inflammatory conditions. CD 
may affect the entire gastrointestinal tract and is associated with an increased risk of colon cancer. 
CD has long been appreciated to have a genetic basis and involves a response of the immune system 
to the natural intestinal flora and some environmental agents. There is currently no cure for CD. 
 
Advances in understanding pathogenesis and developing therapies are hastened by the use of 
effective animal models of inflammatory diseases. In Crohn´s disease, a variety of models have 
been used, including the IL-10 knockout mouse. However, in order to be truly valuable, the disease 
activity in the model and its respond to existing therapy needs to resemble the human disease.  
 
Objective 
In the light of recent development of new biologics therapies this project is set out to  
1) Develop assays for careful evaluation of disease activity in the IL-10 knockout model of colitis. 
2) Compare spontaneous colitis in the IL-10 knockout mouse with a piroxicam induced colitis. 
3) Validate the IL-10 knockout model by examining its response to various biologic therapies e.g. 
(anti-TNF-α, anti-IL-6, anti-IL12p40 and CTLA-4-Ig). 
4) Increase our knowledge concerning key drives and pathways in the IL-10 knockout model for the 
most accurate evaluation of novel targets. 
 
Methods 
Standard immunological assays incl. ELISA, FACS, Medonic, MACS cell purification and in vitro 
cell culture techniques. 
Standard histopathological analysis and endoscopic analysis. 
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Development of targeted human therapies often requires surrogate drugs or targets for preclinical 
evaluation in vivo. The aim of this study is to develop a mouse model where human immune cells 
mediate an inflammatory disease, allowing the investigation of novel anti-inflammatory therapies 
targeting molecules unique to human immune cells. 
 
Non-obese diabetic (NOD)/severe combined immunodeficient (SCID) interleukin-2 receptor 
gamma-chain (IL-2Rγ)null or NOD/recombination activation gene-1 (Rag-1)null IL-2Rγnull mice were 
reconstituted with 20x106 human peripheral blood mononuclear cells (PBMCs) from healthy donors 
and monitored for human immune cell engraftment and development of GvHD. 
In both strains, human CD45+ cells expand in vivo reaching ~50% of all white cells in the blood 
within 3-4 weeks post injection. Engraftment mainly consists of T cells (CD4+ and CD8+), which 
show polyclonal expansion and acquire an activated (CD62L-CD45RO+) phenotype capable of 
secreting cytokines i.e. TNFα, IFNγ, IL-10 and IL-2. After ~4 weeks, mice develop a lethal GvHD 
measured as >20% weight loss and histologically presents with heavy mononuclear infiltration in 
the liver, kidney and lung. Injection of CD8+ T cell-depleted PBMCs attenuates GvHD, whereas 
CD4+ T cell-depleted PBMCs shows sustained GvHD activity. Treatment with Enbrel (soluble 
TNFαR2-Ig) significantly postpones time to GvHD, whereas Orencia (CTLA-4-Ig) can completely 
inhibit GvHD, validating that the model can predict responses of relevant targeted anti-
inflammatory treatments.  
 
In conclusion, we have established a mouse model supporting significant human immune cell 
engraftment and expansion, coinciding with the development of GvHD, which responds to anti-
inflammatory biologics. We predict that this model will be a valuable new tool for preclinical 
evaluation of novel targeted anti-inflammatory therapies.  
 
 
 
  
